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Abstract
Cognitive tests are typically scored and interpreted using an appropriate normative
reference group, often similar age individuals with similar levels of education.
Psychometric testing theory presupposes that demographic correction is always
beneficial, supporting the ubiquitous use of age and education correction in clinical
practice. In the context of dementia, however, there is some evidence suggesting that
demographic correction (specifically age correction) may reduce the sensitivity of
cognitive tests to age related cognitive decline. It was hypothesized that age correction
would reduce the utility of cognitive tests for detecting cognitive change in individuals
with mild cognitive impairment and mild dementia due to Alzheimer’s disease. This
hypothesis was investigated using the National Alzheimer’s Coordinating Center
(NACC) database. NACC data are contributed by the NIA-funded Alzheimer’s Disease
Centers (ADCs). A series of hierarchical multiple linear regressions predicted the CDR®
Dementia Staging Instrument Sum of Boxes Score (CDR-SB) from domain specific
composite scores derived using different types of demographic correction (i.e., no
correction, age correction, education correction, and both age and education correction).
When looking at memory scores alone, raw scores captured more variation in the CDRSB. However, when using a typical neuropsychological (NP) battery approach, correcting
for education only produced a superior model. Findings may be used by clinicians for
positive social change by recognizing that a diagnosis between normal cognitive aging
and dementia is never determined by a single cut off score in clinical practice, correcting
for education is an essential component when processing standardized test scores.
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Chapter 1: Introduction to the Study
The overarching purpose of this study was to investigate the impact of
demographic correction on the diagnostic validity of cognitive tests when differentiating
between normal cognitive aging and dementia, because it was not clear how to best use
normative data in dementia diagnostic evaluations. This goal was achieved by
constructing a series of cognitive composite scores from tests subject to different types of
demographic correction (i.e., uncorrected test scores, age corrected test scores, education
corrected test scores, as well as age and education corrected test scores) and examining
their relationship with a gold-standard measure used to determine the presence or absence
of dementia, the CDR-SB.
The fields of education and psychology recognize standardized testing and normreferenced scoring as a significant method of collecting meaningful information about
individuals and groups. The American Educational Research Association (AERA) in a
joint committee with the American Psychological Association (APA) and the National
Council on Measurement in Education (NCME) asserted, “Educational and psychological
testing and assessment are among the most important contributions of cognitive and
behavioral sciences to our society” arguing that better decisions are made with their
proper use (AERA, APA & NCME, 2014, p.1). Psychological testing plays a big part in
the diagnosis of dementia, a progressive cognitive decline that is serious enough to take
away a person’s independence. Since more people are surviving into old age, the period
of highest risk for cognitive deficits related to dementia, the number of people that can be
helped using a NP measurement perspective is increasing.

2
It is imperative to diagnose the condition early and with accuracy, as by the time
clinical symptoms are clear enough to make a definitive diagnosis, too many neurons
have already been destroyed and the damage is irreversible. There is a need to gain
empirical characterizations of normal cognitive aging, mild cognitive impairment (MCI),
and dementia using comprehensive NP methods (Bondi et al., 2014). Standardized testing
using normative methods provides a comprehensive assessment of general cognitive
functioning that identifies strengths and weaknesses in examinees with a variety of
neurological conditions. While brief global cognitive assessment screening measures like
the Montreal Cognitive Assessment (MoCA) and the Mini-Mental State Examination
(MMSE) are used to delineate between healthy aging and dementia using cut off scores,
they are limited in their sensitivity to cognitive impairment and do not reliably
differentiate normal from diseased individuals until late in the course of the illness
(Malek-Ahmadi et al., 2015; Roalf et al., 2013; Stephan et al., 2017).
Psychometric theory has long recognized that the individual’s performance on
standardized tests is strongly related to demographic variables such as age and education.
For example, an 80-year-old man with 8 years of education cannot be expected to achieve
the same memory performance as a 30-year-old with 20 years of education. Clearly,
comparing the elderly individual’s performance to that of the 20-year-old in this scenario
would be inappropriate. Rather, cognitive testing is typically interpreted using
demographically corrected scores that allow an “apples to apples” comparison. In the
example above, the 80-year-old man’s performance would be demographically corrected
by comparing his performance to other similar aged individuals with similar levels of
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education. Therefore, it is standard practice to demographically correct test scores for age
and education to increase their sensitivity to detecting impairments and facilitate test
score comparison to an appropriate normative cohort (Heaton et al., 2004; Malek-Ahmadi
et al., 2015; Petersen et al., 2014; Quaranta et al., 2016; Smith & Bondi, 2013). In certain
cases, demographic correction may enhance sensitivity to cognitive changes. For
example, if the 20-year-old in the example above is compared to other young, highly
educated individuals, then the stringent expectations placed on his performance are more
likely to reveal a change has occurred (Heaton et al., 2004; Malek-Ahmadi et al., 2015;
Quaranta et al., 2016; Schoenberg & Scott, 2011).
The current debate is whether the use of a normative system universally
improves diagnostic accuracy in an aging population. Researchers argue that current
norms may underestimate the presence of cognitive impairments in the older population
because the norms are contaminated with undiagnosed cognitively impaired individuals
(Hassenstab et al., 2016; Hessler et al., 2014; O’Connell & Tuokko, 2010). If individuals
with undiagnosed impairments are present in “normal samples” of healthy elderly, then
this decreases the performance expectations for the group as a whole and increases
variability, thus obscuring the detection of change (Hassenstab et al., 2016; Hessler et al.,
2014; O’Connell & Tuokko, 2010). Considering that the base rate of dementia becomes
incredibly high, around 40% over age 80 (Alzheimer’s Association [AA], 2018) this is a
serious problem for NP research. A limited number of studies suggested that raw test
scores or education-only test scores may be more sensitive to impairment (Hassenstab et
al., 2016; Hessler et al., 2014; O’Connell & Tuokko, 2010). The use of partially corrected
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and uncorrected test scores has not been rigorously empirically evaluated, and further
research on this topic is justified (Smith & Bondi, 2013).
It is imperative to continually monitor changes and revise key documents in this
rapidly evolving field to develop the utility of this body of knowledge (AERA, APA &
NCME, 2014; Smith & Bondi, 2013). When a rival hypothesis challenges the status quo,
the validation process must continue to obtain empirical evidence by conducting a logical
analysis that evaluates the new proposition. Outcome studies using comprehensive NP
testing to reveal the patterns and profiles of cognitive dysfunction are critically needed to
move the field significantly forward (Bondi et al., 2014; Malek-Ahmadi et al., 2015;
Smith & Bondi, 2013). Important contributions can be made to the field if the findings of
this investigation support that one set of scores (a) raw scores, (b) scores that are only age
corrected, (c) scores that are only education corrected, or (d) a combination of age and
education correction demonstrate better predictive power of the patient’s dementia
severity as measured by the CDR-SB. This study addressed the specific need to
differentiate normal aging and dementia using cognitive testing and various combinations
of demographic corrections (normative data) to examine the strength of the test scores’
relationship to the patient’s clinical status.
Problem Statement
The rapid growth of our oldest population, referred to as the “silver tsunami”, will
cause an unprecedented challenge to our health care industry, namely our Medicare
system (AA, 2018; Gill, 2015; He et al., 2016). Because age is the number one risk factor
for cognitive impairment due to Alzheimer’s disease (AD) and other types of dementia,
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the natural increase in dementia cases will create historically high financial demands for
medical expenses and ongoing personal care needs (AA, 2018; Gill, 2015; Smith &
Bondi, 2013). It is estimated that costs will exceed $47 trillion for medical and long-term
care expenses for all the individuals in the United States alive today that will develop
dementia (AA, 2018, Zissimopoulos et al., 2014). Researchers are in search of a set of
predictors to differentiate those who are experiencing normal cognitive decline due to
aging from individuals who are in the process of developing dementia, an irreversible
neurodegenerative process. NP methods may be ideal for that purpose.
Significant medical, emotional, and social benefits for both the individual and
their families will result from our ability to differentiate between normal aging, MCI, and
dementia earlier and more accurately. The presumed benefit to identifying cognitive
impairment earlier is that cognitively impaired individuals are at higher-than-average risk
of transitioning into dementia (AA, 2018; Dubois et al., 2016; Hessler et al., 2014; Langa
& Levine, 2014; Petersen et al., 1999; Smith & Bondi, 2013). Diagnostic accuracy of
early dementia is critical because secondary prevention trials, disease-modifying
treatments, need to be administered early in the disease process before too much damage
has been done (AA, 2018; Dubois et al., 2016; Rockwood et al., 2014; Smith & Bondi,
2013; Sperling et al., 2011; Ward et al., 2013; Zissmopoulos et al., 2014).
There is no single universally accepted test for dementia. A differential diagnosis
requires a thorough workup that includes laboratory, structural neuroimaging, neurologic
and clinical information. In alignment with psychometric theory, it is widely recognized
that an individual’s performance on standardized tests is strongly related to demographic
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variables such as age, education, sex, and ethnicity, therefore raw scores are “corrected”
to increase the test’s sensitivity to impairment (Heaton et al.; 2004; Malek-Ahmadi et al.,
2015; Quaranta et al., 2016; Schoenberg & Scott, 2011;). However, there is a lack of
empirical evidence that these demographic corrections improve cognitive testing’s
accuracy in late adulthood.
Researchers now question whether the demographically corrected normative
system universally improves diagnostic accuracy (Hassenstab et al., 2016; Hessler et al.,
2014; Holtzer et al, 2008; O’Connell & Tuokko, 2010). The current study was an
outcome study that examined the relationship between the tests, normed different ways,
and the dementia diagnostic status, with the goal of finding which way of scoring best
captured the real-world changes associated with dementia. Because demographic
corrections had not been rigorously empirically evaluated in late adulthood, further
research into this area was warranted to determine if raw test scores may demonstrate
superior sensitivity for differentiating between normal aging and dementia.
Purpose
The purpose of this quantitative study was to identify optimal normative methods
for detecting pathologic cognitive change in elderly individuals. This was achieved by
examining the manner in which demographic corrections for age alone, education alone,
and age and education together affected the relationship between the NP test scores and a
patient’s clinical dementia severity as measured by the CDR-SB. Individuals with normal
cognition, mild cognitive impairment (i.e., predementia, and mild dementia due to AD
served as the study population. Analyses proceeded in three steps. First, tests were scored
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using four different methods of demographic correction (i.e., no correction, age
correction, education correction, age and education correction). This yielded four
different sets of test scores. Second, test scores were aggregated into cognitive composite
scores (i.e., one set of composite scores per norming method). Finally, the relationship of
each set of cognitive composite scores to dementia severity status was analyzed using
four different hierarchical linear regressions to determine which normative method
captured the most variance associated with the cognitive changes that accompany
dementia. The R2 values from these different regressions were compared across the
different norming methods to identify which method of demographic correction was most
strongly associated with the dementia severity status. Akaike’s Information Criterion
(AIC) was calculated and evaluated using published cutoffs frequently used to compare
non-nested models (Burnham & Anderson, 2004).
Multiple regression was ideally suited for this task given that it is explicitly
designed for examining the magnitude of association between a set of continuous
predictor variables and a continuous outcome variable (Field, 2013). In this study,
composite scores derived from tests scored using four different methods of normative
correction served as the continuous predictor variables in four different hierarchical linear
regressions (i.e., one for each norming method) modeling the CDR-SB, a gold-standard
measure of the extent to which cognitive loss interferes with an individual’s real-world
functioning ([dementia status]; Burke et al., 1988). As above, the R2 values and AIC
values from the different regressions were compared across norming methods, to
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determine which method best captured functional decline due to cognitive impairment in
MCI and AD dementia.
Because the order of entry into a hierarchical linear regression model greatly
impacts the results, the order of entry was defined a priori, based on prior work. This
facilitated comparability across models. It was hypothesized that memory and executive
function would be most strongly related to dementia severity status, followed by
language and attention function. Impairments in memory and executive functioning have
been established as prototypical early changes in presentations of AD (Karantzoulis &
Galvin, 2011). It was also predicted that age-adjustment would decrease the magnitude of
the association between cognitive test scores and the CDR-SB while educationadjustment would increase the magnitude of association between cognitive test scores
and the CDR-SB. The findings of this study may aid in determining how to best use
normative data in dementia diagnostic evaluations, identify specific and increase the
understanding of cognitive biomarkers in a specific neurodegenerative disease.
Significance
Malek-Ahmadi et al., (2015) asserted that classification of impairment using
normative data that corresponds with a specific clinical diagnosis is needed to further the
field. Mortamais et al. (2017) argued that secondary prevention trials are hindered by a
lack of proximal cognitive outcome markers. The results of this study may advance the
understanding of the issues raised by these researchers. This project was unique because
it is assumed that we should use age- and education-corrected scores in standardized
testing, but it has not been rigorously empirically evaluated in our aging population
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(Quaranta et al., 2016). Previous researchers who have examined the impact of age and
education corrected scoring focused either on a single test score (Sliwinski et al.,1996;
Sliwinski et al., 1997), or used heterogeneous composite scores that represented multiple
cognitive domains (Hessler et al., 2014). One novel feature of this study was the creation
of domain-specific cognitive scores for (a) memory, (b) executive function, (c) language,
and (d) attention. This allowed for the precise investigation of the extent to which age and
education correction affected the predictive validity of these individual cognitive
domains. This is important because it is unlikely that cognitive domains are affected by
demographic variables in a uniform manner. For example, we know that processing speed
declines with age (Eckert, 2010) but crystallized intelligence such as vocabulary and
knowledge remain relatively stable and may even improve during senescence (Harada et
al., 2013). It stood to reason that age correction might enhance the accuracy with which
changes in processing speed could be detected across the lifespan and is less important
when measuring crystallized knowledge. No studies could be located that examined the
relationship between dementia severity and demographically corrected cognitive test
scores at an individual domain level.
Positive social change results from improvements that promote earlier detection
of neurodegenerative diseases allowing for better treatment planning and prediction of
progression into dementia. The ability to delay the progression of dementia, even just for
1 year, is shown to have significant medical, emotional, and social benefits for the
individual, as well as financial benefits for our nation. Opening this window to earlier
interventions gives the individual more time to seek treatment, learn compensatory
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strategies, and participate in their own care and estate planning. This has the potential to
save money on the historically-costly long course of this disease (AA, 2018; Dubois et
al., 2016; Langa & Levine, 2014; Zissimopoulos et al., 2014).
Background
Francis Galton was credited with launching the modern psychological testing
movement using systematic data he collected on different psychological processes in
1884; not only did he pioneer tests of sensory discrimination, but he also developed the
use of self-report measures (rating scales) along with the statistical methods necessary for
analysis of the data (Anastasi & Urbina, 1997). After a chance meeting with an American
psychologist, James McKean Cattell, a former student of Wilhelm Wundt, Cattell merged
Galton’s new testing movement with what he learned in Wundt’s experimental laboratory
in Leipzig, Germany. Cattell continued his work during his tenure at the University of
Pennsylvania and furthered psychological testing when he proposed a series of 10
different tests and measurements to explore the “constancy”, “interdependence”, and
“variations of mental processes” (Cattell, 1890). Cattell also sketched out rudimentary
methodology for standardized administration in an effort to gain the uniform results
necessary to enable comparisons across different times and places. Cattell’s work helped
spread the interest in quantifying mental abilities to further psychology as a science.
The next hundred years in psychological testing research saw huge leaps forward
with an understanding of measurement error, validation studies, and the development of
norms for different populations (Cortina et al., 2017). Alfred Binet created the first
comprehensive standardized test in 1904 to determine how students would achieve in a
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classroom, and along with his advance came the development of norm-referenced scoring
to estimate the position of the individual within the context of a larger population. In
other words, was the person’s performance “normal” for students of the same age, and by
comparing students to each other he determined if a particular student was ahead-of or
behind the “norm” (Binet & Simon, 1980). Researchers eagerly adopted these statistical
significance and prediction models that emphasized psychometric properties and
classification, and an explosion of new measures and data-analysis innovations were
developed (Cortina et al., 2017).
The use of testing in the field of neuropsychology began around WWII when the
assessment and recovery of brain injured soldiers created a new need in the field of
testing beyond the sensory, vocational, and intelligence testing that was currently
available. Ralph Reitan, a recent college graduate, was given the task of evaluating braininjured soldiers and found a lack of publications available for reference (Grant & Heaton,
2015). The profiles and patterns that were revealed by NP testing became a key
component in making a differential diagnosis, predicting the progression of, and planning
the treatment for neurodegenerative diseases. This research consistently demonstrated
that actuarial methods were a necessary component for comprehensive assessment
(Heaton et al., 2004; Quaranta et al., 2016; Ritchie, et al., 2015; Smith & Bondi, 2013;
Sutphen et al., 2015). The use of a normative system in NP testing, with its roots in the
work of pioneer Alfred Binet, has since been assumed to provide more refined estimates
of cognitive performance and better detection of cognitive impairments (Heaton et al.,
2004; Malek-Ahmadi et al., 2015).
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Normative scores are derived from the performance of a large, diverse normative
sample that demographically represents the U.S. population. Yet some researchers have
argued that despite their attempt at representativeness, it may be advantageous to develop
norms based on specific subgroups and subpopulations to improve the utility of testing
(Brown & Bryant, 1984; Chew et al., 1984; Hassenstab et al., 2016; Holtzer et al., 2008;
Oosterhuis et al., 2016; Svinicki & Tombari, 1981). The aging population may be one
specific subgroup that warrants the use of an alternative method because of the presence
of undiagnosed cognitive impairments in the normative reference population. Researchers
forwarded a proposal that demographic corrections may not improve diagnostic accuracy
in the service of diagnosing cognitive impairment in an older population because the
norms are tainted with individuals who may be in early stages of a degenerative cognitive
decline, which compromises the mean performance and increases the variability in the
normative sample (Hassenstab et al., 2016; Hessler et al., 2014; Holtzer et al., 2008;
O’Connell & Tuokko, 2010; Wyman-Chick et al., 2018). Yet other researchers like
Quaranta et al. (2016) failed to support the hypothesis that raw scores were superior to
age-corrected scores and normative scoring remains standard practice. Wyman-Chick et
al. (2018) argued that the selection of the normative comparison group greatly impacts
both research and clinical interpretations of cognitive data. Yet no studies could provide
rigorously validated impact of demographic corrections on the diagnostic accuracy of
cognitive testing in individual cognitive domains when employed in dementia diagnostic
evaluations. The current study focused on the accuracy of raw scores versus
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demographically corrected scores using an outcome study with a large data set gathered
through the NACC database.
Framework
This study was grounded in testing and measurement theory that governs how
psychological constructs are measured and compared between individuals and groups.
Professor James McKean Cattell (1890) at the University of Pennsylvania wrote about
the benefits of standardized psychological testing, arguing that efforts:
Would be of considerable scientific value in discovering the
constancy of mental processes, their interdependence, and their
variation under different circumstances…the scientific and
practical value of such tests would be much increased should a
uniform system be adopted, so that determination made at different
times and places could be compared and combined. (p. 347)
Frenchman Alfred Binet furthered the utility of testing and measurement in an
educational setting when he developed the first comprehensive standardized test in 1904
as a method of classifying which students could or could not achieve in the classroom.
Binet never claimed that his scale could measure intelligence like a “ruler can measure a
linear surface”, but instead he claimed to provide “…a classification, a hierarchy among
diverse intelligences; and for the necessities of practice this classification is equivalent to
a measure” (Binet & Simon, 1980, p. 41). Binet developed what is now known as normreferenced scoring to allow an estimation of the individual’s position within the context
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of a larger population. Thus, norms became a fact of life in educational and psychological
assessment.
It was quickly realized that much of variance between test scores could be
accounted for by a single demographic variable, and mounting evidence over the
evolution of standardized testing showed that even more variances could be accounted for
with a combination of multiple demographic variables (Barona et al., 1984; Karzmark et
al., 1985; Wilson et al., 1978). The addition of demographic corrections became almost
mandatory in psychological testing because these factors are relevant in an individual’s
diagnosis (Quaranta et al., 2016). In 2004, Heaton et al. published a widely adopted
comprehensive set of demographically adjusted NP norms for more than 50 commonly
used measure for adults ages 20- to 85-years old which helped solidify the use of a
normative system in the field of NP testing at all ages.
Using the established framework, the predictor variables, the demographically
corrected scores, should better predict the outcome variable (the dementia severity rating
as measured by the CDR-SB) because demographically corrected scores are believed to
improve diagnostic accuracy. But researchers argue different reasons that this may not be
true. Manuals for standardized testing give national norms, but the utility of norms is
questioned in an aging demographic. First and foremost, individuals in the normative
sample population may already be transitioning into dementia and contaminating the
norms by lowering the mean performance and increasing the variability in cross-sectional
normative samples (Hassenstab et al., 2016; Hessler et al., 2014; O’Connell & Tuokko,
2010). Similarly, many individuals in an aging normative sample may be prescribed brain
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impairing maintenance medications that also affect their performance and increase the
variability within the sample. Second, is the Flynn effect; norms become less accurate
when too much time passes since publication due to changes in demographics,
socioeconomics, and cultural factors that modify the reference population. Third, norms
become more forgiving and tolerant of errors as age increases, possibly underestimating
the risk of dementia in our oldest population. The current study hypothesized that agecorrected scores would have the lowest magnitude of association with dementia severity
level as measured by the CDR-SB, while education-corrected scores would have a higher
magnitude of association with dementia severity level as measured by the CDR-SB.
Research Questions
The overarching research question was: how does demographic correction for age
and education affect the relationship between cognitive tests and functional deterioration
due to cognitive impairment? Some researchers proposed that raw test scores may have
superior sensitivity for detecting cognitive changes accompanying dementia in an aging
population, over the standard practice of demographically correcting the scores for age
and education level (Hessler et al, 2014; Holtzer et al., 2008; O’Connell & Tuokko,
2010). It is not clear how to best use normative data in dementia diagnostic evaluations
using cognitive testing and there is no consensus in the literature making a rigorous
empirical investigation using an outcome study warranted. Tests will be scored 4
different ways (a) corrected for gender, age, and education (GEA); (b) corrected for
gender and age (GA); (c) corrected for gender and education level (GE); and (d) raw test
scores corrected for gender only (G). Cognitive composite scores representing memory
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and learning, executive functioning, language, and attention were built for each norming
method. Then one multiple linear regression equation per norming method (four total)
was built. These models were then compared by examining the R2 and AIC values to
determine which model “best” captured functional decline due to cognitive loss. The
multiple linear regression equations outlined below were used to determine which set of
scores had the strongest relationship with the patient’s clinically determined dementia
severity level as measured by the CDR-SB.
1. The relationship between the CDR-SB and cognitive composites built from
GEA corrected data.
2. The relationship between the CDR-SB and cognitive composites built from GA
corrected data.
3. The relationship between the CDR-SB and cognitive composites built from GE
corrected data.
4. The relationship between the CDR-SB and cognitive composites built from
“raw” or G corrected test data.
The novel feature of the current study was the creation of domain-specific cognitive
composite scores. There were 4 steps to each regression equation because each composite
score, memory, executive function, language, and attention, was entered into the equation
in a hierarchical fashion allowing for the precise investigation of the extent to which the
demographic corrections affected the predictive validity of each individual cognitive
domain score.
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RQ1: How do age and education correction affect the relationship between cognitive
tests and functional deterioration due to cognitive impairment (i.e., dementia severity)?
H1: Age and education correction increase the extent to which NP tests capture
functional decline due to cognitive loss in dementia. This will be tested by
comparing R2 and AIC values from regression equation 1 with regression equation
4. For example, if the R2 value in equation 1 is moderate (R2 > .25) and the R2
value in equation 4 is strong (R2 > .4) as per conventions from Cohen (1988), then
the null hypothesis can be rejected. Alternatively, if the AIC of model 4 is less
than the AIC value of model 1 by 4 or more (Burnham & Anderson, 2016), then
the null hypothesis can be rejected.
H01: Age and education correction decrease or have no effect on the extent to
which NP tests are able to capture functional decline due to cognitive loss in
dementia.
Sub RQ2: How does age correction affect the relationship between
cognitive tests and functional deterioration due to cognitive impairment?
H2: Age correction decreases the extent to which NP tests are able to
capture functional decline due to cognitive loss in dementia. This will be
tested by comparing R2 and AIC values from regression equation 4 with
regression equation 2. For example, if the R2 value in equation 2 is
moderate and the R2 value in equation 4 is strong, then the null hypothesis
can be rejected. Alternatively, if the AIC of model 4 is less than the AIC
value of model 2 by 4 or more, then the null hypothesis can be rejected.
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H02: Age correction increases or has no effect on the extent to which NP
tests are able to capture functional decline due to cognitive loss in
dementia.
Sub RQ3: How does education correction affect the relationship between
cognitive tests and functional deterioration due to cognitive impairment?
H3: Education correction increases the extent to which NP tests are able to
capture functional decline due to cognitive loss in dementia. This will be
tested by comparing R2 and AIC values from regression equation 4 with
regression equation 3. For example, if the R2 value in equation 4 is
moderate and the R2 value in equation 3 is strong, then the null hypothesis
can be rejected. Alternately, if the AIC of model 3 is less than the AIC
value of model 4 by 4 or more, then the null hypothesis can be rejected.
H03: Education correction decreases or has no effect on the extent to
which NP tests are able to capture functional decline due to cognitive loss
in dementia.
Optimal demographic correction (as determined via the analyses above) will result in
better diagnostic performance when differentiating normal controls from individuals with
dementia. Comparison of the R2 values of the various regression equations presented
above will clarify the extent to which various types of demographic correction (e.g., age,
education, age & education) influence the ability of cognitive tests to detect meaningful
variation in dementia severity. While the above tests are not associated with significance
levels, R2 values and AIC values are used commonly to compare non-nested models and
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allow the important research questions above to be answered quantitatively albeit not
with a given significance level as in a traditional null hypothesis testing approach.
Nature of the Study
This was a quantitative study of concurrent case-referent design for evaluating
test-criterion relationships. This study looked at the relationship between the cognitive
tests, normed different ways, and the clinical dementia severity rating (CDR-SB) using
hierarchical multiple linear regression. Prior to modeling, the data was described by
calculating descriptive statistics including the mean, standard deviation, and a range of all
study variables. The intercorrelations of the cognitive test scores, age, education, and the
CDR-SB was calculated for each of the 4 different norming methods using bivariate
Pearson correlations (one correlation matrix per norming method). The correlations
provided a direct measure of the strength of the relationship between all quantitative
study variables and aided in the interpretation of the hierarchical multiple linear
regression analyses for testing the primary study hypothesis, help detect suppression, and
served as a measure of variable importance (Nathans et al., 2012). Following descriptive
statistics and analysis of intercorrelations between tests, the primary study hypotheses
was tested using least squares hierarchical multiple linear regression. Each set of
cognitive composites, one per norming method, was regressed on the CDR-SB. Because
there are no universally accepted statistical tests by which to compare these non-nested
models, these differences were evaluated quantitatively using R2 values and AIC values,
but were not be associated with a significance level. This told us the extent to which these
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different methods of scoring captured clinically meaningful variations in dementia
severity status and the extent to which they differed from one another.
Hierarchical multiple regression was chosen for this analysis because it allowed
us to fit a model to the data that enabled the prediction of the outcome variable, the CDRSB, from a number of different independent variables, the cognitive tests for each of the 4
cognitive domains scored 4 different ways. This technique is appropriate when examining
the magnitude of association between a set of continuous predictor variables and a
continuous outcome variable (Field, 2013). The comparison of the R2 and AIC values
from the resulting models facilitated an exploration of the extent to which different
scoring methods differed in their ability to capture meaningful variability in dementia
severity status. Identifying optimal norming methods facilitates greater diagnostic
accuracy in the context of dementia.
Sources of Data
The University of Washington’s NACC is funded by the National Institute on
Aging and maintains a valuable resource, a cumulative database with which researchers
can collaborate (NACC, 2010). The NACC shares all data, providing an excellent
resource for investigating cognitive aging and dementia in a well-defined cohort. This
data, the Universal Data Set (UDS), will be obtained from the NACC who took the first
steps to standardize data collection across the ADCs in 1999 in an effort to advance better
research hypotheses; by the end of 2016 data had been collected from 34,748 participants
(Weintraub et al., 2018a). Participants with normal cognition, MCI, and various
etiologies of dementia are recruited and followed annually. Data collection using Version
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3 began in March 2015 as part of an ongoing effort to produce a uniform data set with an
updated NP battery allowing research institutions to collaborate using freely available
standardized instruments (Besser et al., 2018). The current study used the updated 3rd
version of the NACC’s UDS Neuropsychological Assessment Battery (UDS-3 NAB)
which included measures of dementia severity, verbal and nonverbal memory, executive
function, language, and attention (Besser et al., 2018). The instruments produced both
raw test scores and age- and education-corrected scores and were modeled as a function
of the patient’s dementia severity level as measured by the CDR-SB. All identifying
information of the subjects was scrubbed prior to the dissemination of the data to assure
complete confidentiality.
Summary
Since the first standardized psychological testing was used to quantify an
individual’s performance and compare it across groups, norm-referenced scoring was
used to make raw scores more relevant and useful. Researchers draw conclusions about
an individual’s performance by comparing scores to national norms that allow them to
find if the person’s performance is “typical” and determine whether their functioning is
at, ahead, or behind the norm. The presence of appropriate national norms is necessary
for these conclusions. A recent proposal questions the utility of age- and educationcorrected scores in late adulthood, postulating that these norms may be contaminated
with undiagnosed individuals in preclinical or prodromal stages of neurodegenerative
diseases, making the tests less sensitive to the detection of cognitive impairments in our
aging population.
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AD and other dementias are some of the costliest conditions in our society and
predicted to reach crisis levels as our oldest population grows faster than any other
demographic and threatens to place great financial strain on our health care system.
Secondary prevention trials are handicapped by a lack of cognitive outcome markers and
the ability to classify impairment using standard normative data. The current search for a
set of predictors, including cognitive biomarkers, that distinguish individuals who are
experiencing the effects of normal aging from those in the process of developing
neurodegenerative diseases gives rise to the question concerning the utility of raw scores
versus demographically-corrected scores in norm-referenced cognitive testing of an older
population. The current study aimed to explore the strength of the relationship between
tests scored different ways and dementia severity with the ultimate goal of finding which
way of scoring was most diagnostically accurate.
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Chapter 2: Literature Review
The literature review in this chapter justifies the need for additional research to
examine whether the current standard practice of age- and education-correcting scores in
NP testing are best practice when attempting to differentiate between normal cognitive
aging and dementia in an aging population. Some researchers championed the proposal
that national norms are polluted with undiagnosed individuals in the early stages of
dementia, decreasing the tests’ ability to detect cognitive impairment (Hessler et al.,
2014; Holtzer et al, 2008; O’Connell & Tuokko, 2010; Wyman-Chick et al., 2018). But
others failed to support this hypothesis and current practice still adheres to demographic
correction (Malek-Ahmadi et al., 2015; Quaranta et al., 2016). This study addressed a
current debate in the literature over which set of data, normative or raw scores, best
predict the patient’s clinical level of dementia using data obtained from NACC’s ADCs.
The current study may further the utility of NP testing in the service of earlier and more
accurate detection of neurodegenerative diseases because optimal demographic correction
will result in better diagnostic performance when differentiating normal controls from
individuals with dementia.
This chapter starts by addressing the major social problem, the public health
burden of dementia. It then covers an overview of dementia including the concept of
MCI, and the criteria for dementia diagnosis. From there, dementia is discussed starting
with the most common etiology, Alzheimer’s disease (AD), followed by how the testing
profiles of the next common causes of dementia compare and contrast, including vascular
dementia, Lewy body disease, frontotemporal dementia, and Parkinson’s disease. A
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history of psychological and educational testing is explored and connected to the role of
NP testing in a clinical setting with an emphasis on norm referenced interpretation in NP
assessment, methods of norming, and norm referenced interpretation specifically for
dementia diagnostic evaluations.
The literature search included articles electronically accessed through Walden
University library’s databases; Academic Search Complete; Google Scholar; Mental
Measurements Yearbook with Tests in Print; Proquest; psycTESTS; PubMed; SAGE;
Taylor and Francis Online; Thoreau; World Health Organization (WHO), and open
access articles from PubMed.gov and NIH.gov. Other resources such as UpToDate and
Elsevier were accessed through an alternative institution’s library databases. Search terms
included; Alzheimer’s disease; dementia; dementia assessment; diagnostic accuracy and
dementia assessment; diagnostic accuracy and memory impairment; diagnostic accuracy
and mild cognitive impairment; NP assessment and dementia; demographic correction
and neuropsychology and dementia; and demographic correction of NP test scores.
Multiple books, both in print and electronically, were also accessed and reviewed for
relevant information. The search had a rough scope over the last decade with an emphasis
on the last 5 years of research, even though it was necessary to look into the annals of
history when tracing the origins of psychological and educational testing theory.
The Public Health Burden of Dementia
Our healthcare system is about to face an unprecedented challenge as the growth
of our oldest population, the baby boom generation, reaches the age of high risk for the
development of neurodegenerative diseases like AD and other types of dementia (AA,
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2018; Gill, 2015; Livingston et al., 2017; Smith & Bondi, 2013; WHO, 2018;). As the
number of older Americans increases rapidly due to medical advances and better
environmental conditions, so will the number of new cases of dementia. Significant
financial, medical, and emotional benefits will result from earlier intervention because
disease-modifying and psychosocial interventions are most effective early in the disease
process; delaying the onset of the disease, even just for one year, has significant benefits
due to the long duration of the illness prior to death that carries a heavy emotional and
financial burden. (AA, 2018; Dubois et al., 2016; Hurd et al., 2013; Langa & Levine,
2014; Rockwood et al., 2014; Smith & Bondi, 2013; Sperling et al., 2011; Ward et al.,
2013; Wei-Hong et al., 2017; Zissmopoulos et al., 2014).
Lifetime expenditures for an individual with dementia are roughly $341,840, three
times more than the cost of care for people without dementia for the same age group
(AA, 2018). Medicare and Medicaid cover 67% or $186 billion of the total $277 billion
in these costs, deeming this issue a major social problem (AA, 2018). Payments in every
category; primary care physicians; specialists; lab services; medication; emergency room
visits; inpatient hospital stays; skilled nursing facilities; and hospice care are higher for
those with dementia, 23 times greater than those who remain dementia free (AA, 2018).
Even with the financial assistance from Medicare and private insurance, out-of-pocket
expenses are an additional burden to an already emotionally stressed family dealing with
the dementia diagnosis of a loved one.
In addition to medical expenses and lost economic value for unpaid care,
dementia caregivers reported more physical and mental health issues than the general
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population (AA, 2018; Ma et al., 2018; Roth et al., 2015; Solway, 2017). Caregivers
spend an average of 21.9 unpaid hours a week caring for a loved one with dementia (AA,
2018). This often exacerbates their own health issues; increases emotional stress and
depression; and depletes income and finances due to disruption in employment and
additional personal health care expenses (AA, 2018; Ma et al., 2018; Roth et al., 2015;
Solway, 2017). This caregiver strain was even shown to increase the caregiver’s risk of
death (Roth et al., 2015). While most caregivers reported caring for their loved one was
rewarding, they also acknowledged the role is highly stressful (AA, 2018; Solway, 2017).
This is such a prominent issue that the National Academies of Sciences, Engineering, and
Medicine (2016) released a report entitled Families Caring for an Aging America which
focused on national health care reform efforts that recognize the role of family members
and encourage health care providers to deliver evidence-based services to both care
recipients and their caregivers.
Other benefits for the individual include early intervention programs such as
cognitive rehabilitation that maximizes reserved cognitive resources by teaching
compensatory strategies, behavioral interventions like diet and exercise that may increase
quality of life and prolong independence, and estate and care planning while the person
can still participate (AA, 2018; Livingston et al., 2017). Changing the trajectory of AD
and other neurodegenerative diseases has the potential to improve the lives of patients,
their families, and society as a whole.
The WHO (2018) called to prioritize dementia as a global health issue and
reported the prevalence and financial burdens of people living with syndromes of
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cognitive impairment worldwide, proposing the need for public policies to address the
impending crisis:
Almost 9.9 million people develop dementia each year, the majority (63%)
of whom reside in low- and middle- income countries. Dementia currently
affects approximately 50 million people worldwide; a number that is
projected to grow to 82 million by 2030 and 152 million by 2050. It is the
second largest cause of disability for individuals aged 70 years and older,
and the seventh leading cause of death. Dementia imposes an estimated
economic cost of approximately US $818 billion per year globally – or
1.1% of global gross domestic product. Left unaddressed, dementia could
represent a significant barrier to social and economic development. (p. 6)
Research focused on earlier and more accurate diagnoses is part of the formula leading to
improvements in biomedical, psychological, and social interventions that have the
potential to reduce the number of new cases by 10-20% because of their potential to ease
the physical, psychosocial, and financial hardships for individuals, their families, and
developing nations (AA, 2018; WHO, 2018).
Overview of Dementia
Normal or Abnormal Cognitive Aging?
The life-span perspective classifies human development from conception to death,
encompassing all stages and phases of growth, maturity, and aging. Viewing aging
through this lens allows for a model that avoids pejorative or abnormal terms when
psychological processes such as cognition change during the maturation process. It is
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clear that adults peak cognitively between the ages of 20 and 40, but it is also established
that fluid intelligence, efficient functioning of the central nervous system, declines
steadily over adulthood beginning at age 35 or 40 (Boyd & Bee, 2019). Given ample
time, older adults will still come up with the adequate answers, just not as quickly as
younger adults. Using a life-span perspective, cognitive changes due to aging are not seen
as an abnormal condition, but rather a normal developmental stage of life. The difference
between normal cognitive aging and abnormal cognitive aging is an impairment that is
distinct from normal aging, not typical of age-matched peers, and objectively measurable
using NP testing measures.
Cognitive changes are measured by NP testing, tests designed to detect
quantitative or qualitative changes in the main cognitive domains of memory, executive
function, language, attention, processing speed, and visuospatial skills. When an
individual scores > 1 SD below the age corrected normative mean on a testing measure in
a single domain with no interference in Instrumental Activities of Daily Living (IADLs;
e.g., driving, managing one’s finances, self-managing medications, using the community,
etc.) a diagnosis of MCI may be made. When the individual scores > 1 SD below the age
corrected normative mean in multiple domains leading to difficulty with IADLs then a
diagnosis of dementia may be considered. There is a general acknowledgment that
preclinical dementia-related neuropathology is present in normally aging individuals
prior to any measurable cognitive decline (Mortamais et al., 2017; Ritchie et al., 2015;
Rockwood et al., 2014; Smith & Bondi, 2013; Sperling et al., 2011; Sutphen et al., 2015
Ward et al., 2013; Wei-Hong et al., 2017). This grey area, the phase between normal
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cognitive functioning and clinical dementia, is seen as the most promising period for
disease-modifying interventions that have the potential to alter the trajectory of the
disease and has come to be widely accepted as the concept of MCI.
Our ability to predict which patients with MCI will remain stable, typical of
normal aging, versus which will convert to dementia and continue to decline, is a major
goal in current research. NP testing plays an important role in the multidisciplinary search
for answers (Bondi et al., 2014; Smith & Bondi, 2013). NP testing becomes a key frontline component in the detection of preclinical dementia because, unlike a lumber
puncture, it is non-invasive, does not require expensive medical equipment like brain
imaging, and is easy to administer in a variety of clinical settings.
The Evolution of the Concept of MCI
Kral’s (1962) seminal work delineated the difference between “benign” (normal)
and “malignant” (pathological) aging, many terms have been proposed to describe the
concept of the “not-normal but not-demented clinical state”, and MCI has clearly gained
widest acceptance (Smith & Bondi, 2013, pp. 72-73). Petersen et al., (1995) adopted the
term MCI as a diagnostic entity to reflect the earliest objectively measurable deficits in
cognition when it is no longer normal relative to expectations for age, but the individuals
can still live and function independently. The first guidelines for MCI proposed by
Petersen et al. (1999) recommended that general criteria include a non-demented
individual (does not meet the DSM criteria for a dementia syndrome) with generally
intact cognition, preserved Activities of Daily Living (ADLs; e.g., personal hygiene,
continence management, dressing, feeding, and ambulating) and minimal impairment of
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IADLs, but experiencing subjective memory complaints that can be objectively
measured. Smith and Bondi (2013) explained the concept of MCI and its meaning for the
clinician:
MCI constitutes that level of cognitive function wherein low-functioning
normal older persons and high functioning dementia patients cannot be
reliably distinguished. If all persons labeled as MCI are conceived of as
belonging in either a normal population, not destined to develop dementia,
or from a population that is developing dementia, then MCI can be thought
of not as a condition present in the patient, but rather as a state of
uncertainty in the clinician. (p. 73)
MCI was incorporated into the DSM-5 as a mild neurocognitive disorder and is central in
the field because it is considered a significant risk factor for the subsequent development
of dementia. While a percentage of people with MCI remain stable, and a smaller
percentage may recover completely, estimates varied from 43% to 83% conversion rate
to dementia depending on the methodology used; but it is agreed that these patients are at
higher risk for developing dementia (Bondi et al., 2014; Mazaheri et al, 2018; Mitchell &
Shiri-Feshki, 2009; Petersen et al., 1999; Petersen et al., 2013; Petersen et al., 2015;
Smith & Bondi, 2013; Ward et al. 2013; Wimblad et al., 2004). MCI is also important
because it is the window when the least damage has occurred making it an ideal target for
interventions. Thus, the concept defined as MCI has become a primary focus for research
in neurodegenerative diseases.
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Early in the MCI research, total learning score, also referred to as immediate
recall, emerged as the single most sensitive and specific measure for distinguishing MCI
from normal aging; researchers found the addition of a delayed recall measure enhanced
classification accuracy and improved prediction of progression to AD dementia (Bondi et
al., 2014; Smith & Bondi, 2013). As the conception of MCI evolved, it became
recognized as a pathologically heterogeneous disorder and the concept was broadened to
include deficits in other domains besides just memory (Smith & Bondi, 2013; Wimblad et
al., 2004).
A multidisciplinary consensus conference in 2003 expanded MCI into three
subtypes, amnestic, multiple domain, and single nonmemory domain (e.g., language or
visuospatial) and listed multiple possible etiologies; degenerative; vascular; metabolic;
traumatic; psychiatric; and “others” (Wimblad et al., 2004). This was an important
revision in the concept as subcortical dementias like Parkinson’s and Huntington’s
diseases may leave memory relatively intact in the early stages while the first measurable
deficits appear as compromised attention and processing speed (Smith & Bondi, 2013;
Wimblad et al, 2004). Comprehensive NP testing is the best way to classify the specific
subtype of MCI (Bondi et al., 2014; Wimblad et al., 2004).
In 2013, the DSM-5 (APA, 2013) classified MCI as Mild Neurocognitive
Disorder and established the following criteria for diagnosis:
A. Evidence of modest cognitive decline from a previous level of
performance in one or more cognitive domains (complex attention,
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executive function, learning and memory, language, perceptualmotor, or social cognition) based on:
1. Concern of the individual, a knowledgeable informant, or
the clinician that there has been a mild decline in cognitive
function: and
2. A modest impairment in cognitive performance, preferably
documented by standardized neuropsychological testing or,
in its absence, another quantified clinical assessment.
B. The cognitive deficits do not interfere with capacity for
independence in everyday activities (i.e., complex instrumental
activities of daily living such as paying bills or managing
medications are preserved, but greater effort, compensatory
strategies, or accommodation may be required).
C. The cognitive deficits do not occur exclusively in the context of a
delirium.
D. The cognitive deficits are not better explained by another mental
disorder (e.g., major depressive disorder, schizophrenia). (p. 605)
When testing outcome shows that an individual’s memory is significantly lower
than age expectations, but other domains (attention, language, visuospatial skills, and
executive functions) remain intact, amnestic MCI is the preferred classification. If mild
deficits are found in a number of different domains, multidomain MCI (with or without a
memory component) is more appropriate. When one nonmemory domain is impaired,
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such as visuospatial skills, then single nonmemory domain MCI is the most applicable.
After a diagnosis of MCI is made and classified, then the clinician must attempt to
determine the etiology of the impairment and plan for monitoring or treatment. The
differential diagnosis of a cognitive disorder requires an extensive workup given the
serious consequences of progressive degeneration and impending disability. NP testing
plays an important role in the push for earlier and more accurate diagnoses that will allow
for disease-modifying treatments to be developed, tested, and utilized successfully (Bondi
et al., 2014; Mortamais et al., 2017; Smith & Bondi, 2013).
The difference between MCI and dementia is the severity and prognosis. Once the
criteria are met for a dementia diagnosis, there is progression over time. MCI, on the
other hand, while considered a significant risk for future dementia does not always
progress. Current research estimates the majority of patients with MCI transition to
dementia within 5 years of the MCI diagnosis (Mazaheri et al., 2018). Differential
diagnosis demands a comprehensive clinical assessment that includes a full neurological
exam, brain imaging studies, and NP testing (Bondi et al., 2014; Mazaheri et al., 2018;
Mortamais et al., 2017; Petersen et al., 2014; Smith & Bondi, 2013). The early and
accurate diagnosis of MCI is increasingly important as patients are presenting concerns to
their primary care physicians earlier, and secondary prevention trials seek to intervene
sooner in the disease process to limit permanent damage to the brain.
Dementia Criteria
The term dementia is customary in most settings, but the DSM-V reclassified
dementia as major neurocognitive disorder (APA, 2013). Some of the earliest research on
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aging defined two types of changes related to cognition and behavior, “benign” and
“malignant” (Kral, 1962). Benign changes were typical, developmental changes
associated with aging and unrelated to diseased brain tissue, in other words, normal
aging. Malignant changes were histopathological brain changes that were progressive in
nature. As research continued, the focus became the ability to distinguish a normally
aging individual, who was worried about their memory function enough to complain to
their primary care provider, from a malignant or neurodegenerative process (Smith &
Bondi, 2013). Currently, the DSM-V sets the consensus diagnostic criteria for a major
neurocognitive disorder as:
A. Evidence of significant cognitive decline from a previous level of
performance in one or more cognitive domains (complex attention,
executive function, learning and memory, language, perceptualmotor, or social cognition) based on:
1. Concern of the individual, a knowledgeable informant, or the
clinician that there has been a significant decline in cognitive
function; and
2. A substantial impairment in cognitive impairment in cognitive
performance, preferably documented by standardized
neuropsychological testing or, in its absence, another quantified
clinical assessment.
B. The cognitive deficits interfere with independence in everyday
activities (i.e., at a minimum, requiring assistance with complex
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instrumental activities of daily living such as paying bills or
managing medications).
C. The cognitive deficits do not occur exclusively in the context of a
delirium.
D. The cognitive deficits are not better explained by another mental
disorder. (APA, 2013, pp. 602-603)
The DSM-V requires the clinician to specify the etiology of the major
neurocognitive disorder, a discussion of all the causes is beyond the scope of this paper, but
the most prevalent causes are addressed in the following subsections. The most common
cause of dementia is AD. The second most common cause is vascular disease, followed by
Lewy body disease, and frontotemporal lobar degeneration (Ramirez-Gomez et al., 2017;
Smith & Bondi, 2013). While AD, Lewy body disease, and frontotemporal dementia are all
classified as neurodegenerative diseases, vascular disease is more diverse and does not
always conform to the same standards. NP profiles and patterns aid in distinguishing these
underlying pathologies (Ramirez-Gomez et al., 2017; Smith & Bondi, 2013; Stephan et al.,
2017). This is why the number of people that can be helped using a NP perspective is
increasing.
Alzheimer’s Disease
Over a century ago Alois Alzheimer, considered the father of neuropathology,
was the first to describe a patient with the progressive form of dementia that now bears
his name (Möller & Graeber, 1998). AD is the most common cause of dementia
accounting for up to 80% of all cases (AA, 2018; Sutphen et al., 2015). In the United
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States, one person develops the disease every 65 seconds (AA, 2018). Current estimates
support that 10% of people age 65 have AD, with the prevalence of the disease increasing
exponentially with age: three percent of people age 65-74, 17% of people age 75-84, and
over 40% of people age 85 and older (AA, 2018; Hebert et al., 2013).
The first individuals to be born into the baby boom generation turned 72 in 2018,
placing them at high risk for neurodegenerative disorders (AA, 2018). The rapid increase
of our oldest population over the coming decades will stress our health care system as
demand for medical care and long-term services will increase, placing a huge burden on
Medicare that will cause a major economic ripple on our Nation’s budget (Barnett, et al.,
2014; Dubois et al., 2016; Hurd et al., 2013; Rockwood et al., 2014; Zissmopoulos et al.,
2014). Estimates claim a $935 billion in savings that can be realized over the 10-year
period from 2026-2035 with an overall $7.9 trillion savings for the current U. S.
population (AA, 2015). Our Nation will benefit from earlier and more accurate detection
of neurodegenerative diseases like Alzheimer’s because of the potential to improve the
lives of the millions of individuals yet to be diagnosed.
Prior to updated guidelines in 2011, a formal diagnosis of AD required that an
individual already exhibit significant problems with learning, thinking, or memory. The
seminal work of Braak and Braak (1991) changed how AD was viewed based on the
discovery of neurofibrillary tangles (a known biomarker of AD) in people as young as 30.
This sparked a surge of research that led to Jack et al.’s (2010) continuum model of AD
that begins with a preclinical period, decades before symptoms appear but when
biological changes are already taking place in the central nervous system, moving into
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MCI where cognitive decline can be objectively measured, and finally full-blown
Alzheimer’s dementia. This revised model of the Alzheimer’s trajectory continues to
guide most of the current direction in research and practice with the hopes that diseasemodifying interventions will be developed and utilized during the earliest stages to
change the course of the disease prior to total dementia setting in (Jack et al., 2013).
It is certain that a preclinical stage of AD begins decades before symptoms
appear, when biological changes take place, but the individual remains asymptomatic
(AA, 2018; Jack et al., 2013; Jack et al., 2015; Mazaheri, 2018; Mortamais et al., 2017;
Ritchie et al., 2015; Sutphen et al., 2015). This has led some researchers to categorize AD
as a disease of midlife rather than of old age (Ritchie et al., 2015; Sutphen et al., 2015).
Jack et al. (2013) proposed the main AD biomarkers change in a temporally ordered
manner; starting with an abnormal accumulation of amyloid β protein (Αβ) as plaques,
and hyper phosphorylated tau protein as neurofibrillary tangles that can be assessed by
measures of cerebral spinal fluid (CSF) Aβ and tau. This is followed by the biomarkers of
neurodegeneration indicated by brain imaging, hypo metabolism on fluorodeoxyglucose
(FDG) PET, and structural MRI, that finally lead into the clinical symptoms and
measurable cognitive decline (cognitive biomarkers). This insidious onset is included in
the diagnostic criteria for AD. The current model assumes “the maximum rate of change
moves sequentially from one biomarker class to the next, and as the disease progresses all
biomarkers become progressively more abnormal simultaneously…at rates that change
over time in an ordered manner” (Jack et al., 2013, p. 207). The rate of progressive
cognitive impairment is “loosely coupled” with the amount CSF Aβ, but “closely
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coupled” with imaging neurodegenerative biomarkers (Jack et al., 2013). It was also
noted that the time needed to travel the course of the disease varies among individuals
because it is mediated by baseline differences in brain plasticity and cognitive reserve, as
well as the presence of other pathophysiology like cerebrovascular disease or Lewy
bodies, which often co-occur with AD and contribute to an individual’s variation and
presentation (Jack et al., 2013; Karantozoulis & Galvin, 2011; Smith & Bondi, 2013).
In the Alzheimer’s continuum, MCI is thought of as the period that reveals the
first objectively measurable cognitive deficits due to neuropathological brain changes that
occur in the course of the disease, and also where therapeutic trials designed to prevent
cognitive decline are most useful (AA, 2018; Livingston et al., 2017; Mortamais et al.,
2017; Sutphen et al., 2015). Once brain changes are so significant that cognition and
physical functioning decline, risk reduction and medical interventions are of little value
(AA, 2018; Peall & Robertson, 2015). The problem remains in the obvious detail that by
definition of being asymptomatic, the preclinical phase avoids detection using current
cognitive measures. Empirically validated innovations for detection using a NP testing
perspective are critically needed.
Our ability to diagnose individuals earlier and more accurately for the purpose of
testing and utilizing disease-modifying treatments are the key to changing the trajectory
of neurodegenerative diseases. Mortamais et al. (2017) asserted:
The design of secondary prevention trials targeting the preclinical period
has thus been handicapped up to this point by that lack of proximal
cognitive outcome markers. The cognitive tests currently used to describe
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AD, having been largely derived from comparisons of persons with and
without dementia, are by definition inappropriate for preclinical studies.
Such early cognitive changes, if they exist, are likely to be subtle, requiring
highly sensitive tests that target specific brain regions affected early in the
disease process. (p. 469)
AD is a prototypical cortical dementia with the most salient cognitive biomarkers
markers being episodic memory impairments (learning and retention measures), that
when coupled with the presence of a molecular biomarkers, like CSF Aβ and tau or FDG
PET, clinicians can be fairly certain the individual will progress into AD dementia
(Mortamais et al., 2017; Smith & Bondi, 2013). Episodic memory impairment is the most
prominent predictor of dementia, but aphasia and apraxia are also common features and
can be measured by lower performance in verbal fluency, processing speed, and fluid
reasoning (Karantzoulis & Galvin, 2011; Mortamais et al., 2017; Smith & Bondi, 2013).
During recognition memory testing, patients with AD do not benefit from cueing and
tend to show greater false-positive errors (Karantzoulis & Galvin, 2011). As the disease
progresses, language skills continue to deteriorate, and global aphasia and muteness are
common. Traditionally, cognitive dysfunction was viewed as the outcome of AD and
other dementias. Mortamais et al. (2017) argued that increasing evidence supports that
cognitive changes can be detected in preclinical stages of dementia rather than waiting
for a clinical diagnosis and there is a need for “comprehensive evidence-based guidelines
for preclinical cognitive assessment”. The current study attempted to address these needs.
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Vascular Dementia
Vascular dementia (VaD) is an umbrella term that refers to any dementia caused
by impaired cerebral blood flow due to cerebrovascular disease or brain injury. It was
included in the DSM-5 as a major cognitive disorder. VaD is the second most common
form of dementia but it is not classified as a neurodegenerative disease, only AD leads in
incidence. Pure VaD is relatively uncommon, but it is a contributor in an estimated half
of clinical- and population-based studies, most often in combination with AD and
diagnosed as mixed dementia ([MD]; Blom et al., 2014; Kang et al., 2016; Smith, 2017;
Smith & Bondi, 2013). While rare in its pure form, it can cause dementia (RamirezGomez et al., 2017; Smith, 2017; Smith & Bondi, 2013; Stephan et al., 2017). VaD
generally has a more abrupt onset than AD (Karantzoulis & Galvin, 2011; Smith &
Bondi, 2013). Typically, it is identified in one of two ways, either a stroke is diagnosed
which is then followed by the onset of dementia, or a patient with no history of stroke
complains of cognitive decline and neuroimaging or neuropathology reveals the vascular
brain injury (Smith, 2017). Cognitive impairments due to vascular issues are also
diagnosed on a spectrum, with the severity of the vascular disease correlated with the
extent of the cognitive impairment ranging from MCI with a vascular etiology, also
known as vascular cognitive impairment to all-out VaD when the criteria for dementia is
met (Ramirez-Gomez et al., 2017; Stephan et al., 2017). Just like with AD the prevalence
of vascular dementia increases after 65 years of age and factors related to the brains
ability to compensate for the level of pathology makes it difficult to use neuroimaging
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alone to diagnose the severity of VaD. NP testing becomes an important factor in the
comprehensive clinical assessment used make the final diagnosis.
In addition to age, there are other risk factors associated with vascular dementia;
hypertension; diabetes; high cholesterol; sedentary lifestyle; low or high body mass
index; smoking; coronary artery disease; and atrial fibrillation (Livingston et al., 2017;
Smith & Bondi, 2013). Cerebral blood flow becomes impaired through slow cumulative
processes that lead into cerebral small vessel disease or may have a sudden onset from a
single major event such as a hemorrhagic stroke (Blom et al., 2014; Ramirez-Gomez et
al., 2017; Smith, 2017; Smith & Bondi, 2013; Stephan et al., 2017). Cortical signs of
stroke may include aphasia and apraxia, but the NP profile of an individual post stroke
varies because it is directly related to the stroke location and severity (Smith & Bondi,
2013; Stephan et al., 2017). The mere presence of a cerebrovascular brain injury does not
necessarily signal dementia or indicate impending dementia.
There are many different cardiovascular and cerebrovascular incidents that lead to
cognitive dysfunction and different vascular disorders have different patterns of cognitive
impairment (Kang et al., 2016; Ramirez-Gomez et al., 2017; Stephan et al., 2017). People
with vascular dementia tend to experience motor issues more often than those with AD,
such as a slowing of gait, and neuropsychiatric signs like depression, apathy, psychosis,
or sudden and inappropriate laughing or crying known as pseudobulbar affect (Smith &
Bondi, 2013). When vascular dementia is suspected, the cognitive profile is examined
along with a complete health history, risk factors, brain imaging, and the presence or
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absence of biomarkers of other neurodegenerative diseases that may be contribute to
cognitive decline such as the presence of CSF Αβ (Smith & Bondi, 2013).
The NP profile for VaD is typically characterized by poor executive function that
includes decreased inhibition and processing speed; poor planning and problem solving;
and difficulties with task changing, working memory, and attention, but the variety of
incidents that lead to vascular cognitive dysfunction makes it difficult to typify a pattern
across all vascular conditions (Karantzoulis & Galvin, 2011; Ramirez-Gomez et al.,
2017; Smith & Bondi, 2013; Stephan et al., 2017). While episodic memory impairment is
a hallmark of the AD diagnosis, those with VaD typically respond better to recognition
and cueing of learned information (Karantzoulis & Galvin, 2011; Ramirez-Gomez et al.,
2017). Measures of verbal fluency showed greater impairment of phonemic (letter)
fluency in VaD versus greater impairment of semantic (category) fluency in AD
(Ramirez-Gomez et al., 2017). Ramirez-Gomez et al. (2017) found phonemic and
semantic differences alone did not distinguish AD from VaD, but when they generated a
formula that incorporated the first learning trial of a word memory test, they were able to
classify AD from VaD in an autopsy confirmed cohort with moderate sensitivity and
specificity, but asserted additional independent studies were necessary to confirm their
hypothesis.
Vascular dementia may mimic AD depending on the location of the infarct, and
the fact that it is often found in combination with AD as MD makes it even more difficult
when testing profiles have significant overlap (Karantzoulis & Galvin; 2011; Kang et al.,
2016). When comparing a pure AD etiology to MD, the frontal lobe deficit patterns of
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VaD overlap with the medial and lateral temporal lobe deficit patterns of AD. Kang et al.
(2016) found significant differences in the milder stage of dementia where the NP
profiles of MD demonstrated lower performance on executive function and semantic
fluency but maintained a memory advantage over AD into a moderate stage of dementia.
As the severity of the dementia increased, testing patterns and profiles were harder to
distinguish from one another as no significant differences were found in attention,
language, visuospatial, or memory scores (Kang et al., 2016). Another conclusion from
Kang et al.’s study was that AD patients appeared to maintain better ADLs making the
rating of functional performance an important piece of the differential diagnostic puzzle.
The current study includes a clinical dementia staging instrument, CDR, considered a
gold standard for capturing daily functional performance
related to dementia. Clearly the variations in cognitive profiles across VaD make it
challenging to come to a consensus on which cognitive tests best capture the information
needed to support an MCI due to vascular conditions or a VaD diagnosis (Stephan et al.,
2017). Comprehensive testing across all domains allows clinicians to identify cognitive
strengths and weaknesses to rule out alternative explanations for the impairments, and the
use of the CDR as a measure of functional performance helps support the final diagnosis.
Lewy Body Disease
Dementia with Lewy bodies (DBL) is considered one of the three most common
forms of dementia and is the second leading neurodegenerative cause (McKeith et al.,
2017; Smith & Bondi, 2013). It has distinct clinical features including cognitive
fluctuations; hallucinations; rapid eye movement (REM) sleep behavior disorder (RBD);
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and parkinsonism; which typically appear early and persist throughout the course of the
disease (McKeith et al., 2017). Unlike AD and VaD, the incidence of DLB does not
appear to increase with age (Smith & Bondi, 2013). The First International Workshop of
the Consortium on DLB convened in 1996 and established the classification of dementia
with Lewy bodies (Rizzo et al., 2012). The pathologic hallmark of DLB is the Lewy
body, an intracytoplasmic inclusion in deep cortical layers in the brain, especially the
frontal and temporal lobes (McKeith et al., 2017; Rizzo et al., 2017; Smith & Bondi;
2013). While short-term memory is typically the earliest deficit of an AD patient,
impaired visuospatial function, attention, and executive function appear to be the most
prominent deficits in early DLB (McKeith et al., 2017; Rizzo et al., 2017; Smith &
Bondi, 2013). In fact, an absence of visuospatial impairment helps clinicians exclude
DLB. Attention deficits vary from seconds to days and are interspersed with periods of
near normal function; they may take the form of a brief cognitive fluctuation that
interrupts the flow of an ADL or be severe enough for the individual to appear catatonic
for a length of time (Smith & Bondi, 2013; McKeith et al., 2017). The CDR helps capture
these fluctuations in consciousness.
Visual hallucinations are rare in AD but occur in up to 80% of individuals with
DLB (McKeith et al., 2017). They are an early sign of DLB and are often under reported
because the patient has a lack insight regarding the nature of the hallucinations. They
may come in the form of people, animals, or inanimate objects that move or shape shift;
or even more complex visual interactions like ongoing conversations with the dearly
departed. Auditory hallucinations, hearing music, a TV, or voices nearby; olfactory

45
hallucinations, both pleasant and foul; and tactile hallucinations like feathers or fur
brushing up against an arm or leg, or even insects crawling on their skin are also present
in patients with DLB (McKeith et al., 2017). Another early sign that occurs in 85% of
individuals and may precede clinical diagnosis by up to 20 years is RBD, characterized
by recurrent dream enactment and vocalizations (Donaghy et al., 2018; McKeith et al.,
2017; Smith & Bondi, 2013). It can be mild or severe, and injuries can happen from
striking a bed partner or suddenly jumping out of bed. RBD is not exclusive to DLB and
can also occur in patients with Parkinson disease dementia. Gait disorders, limb rigidity,
or a combination of the two, termed parkinsonism, is also present in 70%-90% of patients
with DLB but usually in a milder degree than someone with Parkinson’s disease.
These types of overlapping clinical features make differential diagnosis
challenging which is why NP testing plays an important role in a comprehensive clinical
assessment to avoid serious negative side effects of certain treatment protocols. DLB
continues to be under-recognized, and misdiagnosed as AD or Parkinson’s disease, so
there is a need to refine diagnostic criteria to improve sensitivity and specificity as
treatment efficacy is highly specific to DLB (McKeith et al., 2017; Rizzo et al., 2017).
There are serious consequences when DLB is treated with the wrong types of
medications; 30% to 50% of patients with DLB have severe antipsychotic sensitivity with
reactions that may include irreversible parkinsonism, impaired consciousness, and even
death (McKeith et al., 2017; Smith & Bondi, 2013; Rizzo, et al, 2017). These reactions
are less common in Parkinson’s disease and have not been observed in AD. Donaghy et
al. (2018) concluded the addition of neuropsychiatric symptoms other than hallucinations
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(e.g., delusions, anxiety, depression, and apathy) to the core diagnostic features supported
the differential diagnosis between DLB and AD.
The NP profile of DLB is a mixture of cortical and subcortical symptoms
characterized by disproportional impairment in visuospatial, attention, and executive
functions early on (Karantzoulis & Galvin, 2011; McKeith et al., 2017; Smith & Bondi,
2013). When memory is impaired, usually later in the disease, encoding is typically less
affected than retrieval; object naming is also typically preserved (Karantzoulis & Galvin,
2011; McKeith et al., 2017; Smith & Bondi, 2013). No specific testing battery has been
developed (Donaghy et al., 2018; McKeith et al., 2017), but comprehensive measures that
includes spatial and perceptual tasks like complex figure copy and line orientation, and
executive and processing speed measures like trail making tests and coding, are
especially helpful in the differential diagnosis process when used in tandem with word
memory lists, and object naming tasks.
Frontotemporal Dementia
Frontotemporal dementia (FTD) has become an umbrella term for a group of
clinically heterogeneous degenerative disorders affecting the frontal lobe alone, an
isolated temporal lobe, or a degeneration of both the frontal lobes and temporal lobes.
The most common subtypes are the behavioral variant (bvFTD) and two forms of
Primary Progressive Aphasia (PPA), nonfluent and semantic variants (Lee, 2019;
Ravskoski et al., 2011; Smith & Bondi, 2013). The main symptoms of bvFTD are
persistent and significant changes in behavior and personality, while the main changes in
PPA are a progressive deterioration of language skills. Because the pathology of each
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variant is different, a consensus on the neuropsychology of FTD remains elusive. When
contrasted with AD, memory is spared in the early course of the disease with better recall
and recognition across all FTD syndromes (Smith & Bondi, 2013). Wittenberg et al.,
(2008) asserted that the difficulties to finding a consensus stems from still evolving
diagnostic criteria, inconsistent findings in research, and the rare prevalence of FTD.
Smith and Bondi (2013) claimed that FTD accounted for only about 5% of all dementias
in an unselected autopsy series.
The most common subtype bvFTD accounts for nearly 50% of all FTD cases with
an onset most common in the 6th decade of life but uncovered as early as the 2nd decade
and as late as the 9th decade of life with only a 0.02% incidence rate in the general
population (Lee, 2019). The primary characteristics are the pervasive behavioral changes
that are often ignored or misdiagnosed for several years causing significant impact on the
caregiver stress levels before a formal clinical diagnosis (Lee, 2019; Smith & Bondi,
2013). Rascovsky et al. (2011) included the following symptoms in their outline for
diagnostic criteria:
A. Disinhibition – inappropriate and embarrassing public behavior
B. Apathy, inertia, loss of sympathy, empathy, or changes in humor –
indifference to others’ needs and feelings, less warmth and affection
C. Hyperorality – changes in food preferences or decline in table manners
D. Compulsive behaviors – obsessions with new hobbies or interests; smoking,
alcohol use; or new religious and spiritual pursuits
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E. A neuropsychological profile that shows a relative sparing of memory and
visuospatial functions with deficits in executive functions
It is challenging to interpret NP test results in many patients with bvFTD due to
substantial overlapping profiles with other neurodegenerative diseases. First, other
medical illnesses (infarction, tumors, abscess, or trauma), substance abuse, psychiatric
disorders, and other dementias such as AD or LBD must be ruled out (Lee, 2019; Smith
& Bondi, 2013). Because individuals with bvFTD rarely have insight into their
behavioral changes, a proper diagnosis is heavily dependent on the testimony of a
knowledgeable informant. This is obtained via informant interviews during the clinical
interview and through the CDR, a structured interview and informant testimony. Clearly,
the significant personality and behavioral changes in bvFTD dwarf any behavioral
disturbances present in AD, but in the temporal variants that are discussed below
language and semantic knowledge are the most pronounced deficits.
The other syndrome of FTD is PPA characterized by an insidious onset of
progressive language impairment that is evident in the early stages of the disease;
prevalent deficits in word finding, word comprehension and usage, and sentence
construction are present while other cognitive domains and ADLs are relatively spared
(Gorno-Tempini et al., 2011; Mesulam, 2013; Smith & Bondi, 2013). Two variants of
PPA have been delineated based on the type of language impairment; nonfluent or
agrammatic, and semantic (Gorno-Tempini et al., 2011; Smith & Bondi, 2013). Word
finding is the common feature across both subtypes of PPA, but the nonfluent variant has
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more pronounced articulation problems while the semantic variant has more pronounced
comprehension difficulties.
The main characteristic of nonfluent PPA is apraxia of speech as demonstrated by
effortful, halting speech with speech-sound errors or distortions and agrammatism in
language production; comprehension is spared for single words and simple sentences, but
complex syntax poses problems (Smith & Bondi, 2013; Gorno-Tempini et al., 2011).
The semantic variant PPA is marked by preserved fluent output, but simple
comprehension becomes impaired through a loss of single word or object meaning and as
the disease progresses comprehension becomes more globally impaired, episodic memory
may decline, and behavioral symptoms such as rigidity of personality and loss of
empathy may emerge (Mesulam, 2013; Smith & Bondi, 2013). A differential diagnosis is
made by first ruling out other medical issues like cerebrovascular disease or tumors, then
testing is used to discern the pattern of language deficits; the patient must also initially
present with no impairments of episodic or visual memory, no visuospatial impairment,
and no prominent behavioral disturbances (Lee, 2019). There is inconclusive evidence for
the utility of NP testing in the diagnosis of FTD as the pattern of executive dysfunctions
has not been distinguished from AD (Smith & Bondi, 2013). The challenges remain to
improve the utility of NP testing and to clear the confusion behind the diagnostic criteria
of FTD.
Parkinson’s Disease
Parkinson’s disease (PD), once considered a disorder of only the motor system, is
now widely recognized as a clinically diverse disease with three major subtypes; two of
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which have more neuropsychiatric and nonmotor manifestations in addition to motor
symptoms (Chou, 2019). The traditional tremor-dominant subtype has slower progression
and less cognitive impairment than the akinetic-rigid subtype and the postural instability
and gait difficulty subtype (Chou, 2019). The common clinical motor manifestations
include tremor, bradykinesia, rigidity, and postural instability, while 97% of patients also
present with nonmotor symptoms, some which manifest before motor symptom onset:
•

Cognitive dysfunction and dementia

•

Psychosis and hallucinations

•

Mood disorders – depression, anxiety, and apathy

•

Sleep disturbance

•

Fatigue

•

Autonomic dysfunction

•

Olfactory dysfunction

•

Gastrointestinal dysfunction

•

Pain and sensory disturbances

•

Dermatologic findings - seborrhea

•

Rhinorrhea

PD and DLB share many overlapping clinical symptoms and pathological similarities
such as parkinsonian features, psychosis, visual hallucinations, and fluctuating cognition
making the differential diagnosis even more challenging (Chou, 2019). Clinicians and
researchers use the convention of the “one-year rule”; if motor symptoms begin more
than a year prior to the onset of dementia, then PD is diagnosed. When motor symptoms
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present concurrently, or they start during the same year, then the diagnosis of DLB is
given.
Cognitive dysfunction and dementia are common in PD with an estimated 78%
incidence rate of dementia uncovered in longitudinal studies (Chou, 2019; Rodnitzky,
2018). Subcortical dementias like PD typically spare memory in the early stages with the
first NP manifestations appearing as psychomotor retardation, compromised executive
function, and impaired attention and processing speed (Chou, 2019; Smith & Bondi,
2013). As the disease progresses memory recall and visuospatial skills are more notably
impaired with full dementia typically setting in later during the course of the disease.
Cognitive testing plays a large role in determining the etiology of AD and all other types
of dementia.
The History of Educational and Psychological Testing
Anastasi and Urbina (1997) wrote the classic comprehensive text on
psychological testing that is still widely used in graduate programs. The authors wrote,
“The roots of testing are lost in antiquity” (p. 32) but sketched an outline of the groundbreaking pioneers that laid the foundation for educational and psychological testing as a
valid and reliable method for collecting meaningful data about individuals. English
biologist Francis Galton launched the modern testing movement when he established the
need to measure characteristics of related and unrelated persons in the effort to further his
research interests in heredity, leading to the first large systematic collection of data from
his anthropometric laboratory (Anastasi & Urbina, 1997). In addition to developing
rating-scales and self-report questionnaires, Galton also advanced the statistical methods
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necessary for data analysis. Around the same time American psychologist James McKeen
Cattell has just finished his dissertation on reaction time under the tutelage of Wilhelm
Wundt in the first experimental psychology laboratory in Leipzig, Germany. Cattell’s
chance encounter with Galton in 1888 while lecturing at Cambridge University, inspired
Cattell to merge Wundt’s newly established science of experimental psychology with
Galton’s even newer testing movement. The result of this early work was an upsurge of
interest in testing and measures designed to quantify and classify human behavior and
cognition.
Frenchman Alfred Binet built on that foundation and constructed the first
comprehensive test of intelligence in 1905 at the request of the Minister of Public
Instruction in an effort to create proper procedures to educate children with mental
retardation (Anastasi & Urbina, 1997). The 1905 scale, as it was known, originally
consisted of 30 problems that required comprehension, reasoning, and judgment and was
arranged from least to most difficult. The scale was administered to 50 “normal” children
aged 3 to 11, and other children and adults with mental retardation. This preliminary
scale had no objective method for arriving at a total score, but it caught the attention of
psychologists around the world and was translated and adapted in many countries,
including the United States. In the revised version, the 1908 scale, the researchers
dropped the unsatisfactory tests and added others that had more promise. Simon and
Binet then collected data on 300 normal children and grouped the results by age level.
Any tests passed by 80 to 90% of normal 3-year-olds were grouped into a 3-year level; all
tests passed by 4-year-olds were grouped into a 4-year level; and the same was done with
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each age group up to 13. Thus, the foundation for a normative scoring system as a
uniform frame of interpretation and reference was based on research with children, but
Binet’s ill-timed death in 1911 left much work to be done.
L. M. Terman and associates from Stanford University adopted Binet’s work in
1916 and used it to build the broader and more psychometrically sound Stanford-Binet
coining the use of a ratio between mental age and chronological age as an intelligence
quotient (IQ). The work of these early psychometricians quickly diffused throughout the
world and standardized psychological and educational testing forged ahead as an
explosion of new measures and methods for analyzing data quickly followed. The
Journal of Applied Psychology (JAP) chronicles the history that led to our understanding
of measurement error and validation, as well as many other methodological areas of
psychological testing (Cortina et al., 2017). From 1917 to 1925 the journal published the
early work on the development and norming of cognitive ability testing for different
populations and the beginning of statistical significance and prediction models with
emphasis on psychometric properties and classification. Over the next 40 years, work on
test scoring methods and cross validation dominated the publication while the following
43 years witnessed an explosion of new measures and the data-analysis innovations that
came along with them (Cortina et al., 2017). The current study builds upon the work of
these early psychometricians and examines subgroup differences to validate optimal
norms for an aging population.
The use of testing in the field of neuropsychology began around WWII when the
evaluation and recovery of brain injured soldiers created a new need in the field of testing
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beyond sensory, vocational, and intelligence testing. Ralph Reitan, a recent college
graduate, was given the task of assessing these brain-injured soldiers and found a lack of
publications available for reference (Grant & Heaton, 2015). With the help of the
hospital’s chief neurologist, John Anita, they published a series of four articles on the
psychological consequences of brain injury. Anita encouraged Reitan to consult with
psychologist Ward Halstead who he had seen lecture on the effects of brain injury.
Through his new relationship with Halstead, he met Louis Thurston a mathematical
psychologist from the University of Chicago Medical School and together the men
encouraged Reitan to enter a graduate program in psychology (Grant & Heaton, 2015).
“Through a combination of mishaps and serendipity”, Reitan ended up splitting his
studies between medical school and psychology; and as a graduate student Reitan tested
patients in Halstead’s laboratory using the instruments Halstead developed (Grant &
Heaton, 2015). The brain-behavior relationship began to unfurl as data was gathered
through testing, medical, surgical, and autopsy channels and the field of neuropsychology
was born. Reitan’s work:
…refined and standardized what most neuropsychologists now take for
granted as they write their reports: the approach to inference in individual
cases that takes into account such information as levels of performance,
patterns of test results, right-left comparisons, and pathognomonic signs.
(Grant & Heaton, 2015, para. 3)
The Halstead-Reitan battery is a collection of NP tests that assess the functioning of the
brain and is still used both in its complete form and as individual test components today.
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The Role of Neuropsychological Testing in Clinical Settings
NP testing and measurement play an important role in diagnosis, prediction of
progression, and treatment planning for neurodegenerative diseases because research
demonstrates that these actuarial methods are superior to clinical judgment alone (Smith &
Bondi, 2013). The FDA established cognitive measures in this critical role when they
required NP measures be included as a co-primary outcome in research studies seeking to
demonstrate efficacy in dementia treatments (Leber, 1990). A test is defined as any set of
tasks, procedures, or stimuli designed to elicit responses that sample an examinee’s
performance or behavior in a specified domain, while assessment is the broader term
referring to the process that integrates the gathered data with other sources of evidence
such as interviews about a participant’s social, educational, employment history, health
history, and psychological history (AERA, APA & NCME, 2014). NP testing batteries
gather quantified and meaningful data about an individual’s various cognitive and
behavioral domains for diagnostic or predictive value, yet the final diagnosis should
always include a full assessment including physical and neurological examinations, the
patient’s medical and family history, and blood tests or brain imaging to rule out other
potential causes of cognitive impairment.
As there is no single test for dementia, a variety of different measures are used
during an assessment to take an inventory of the strengths and weaknesses of the major
cognitive domains including verbal and nonverbal IQ, memory domains that encompass
both encoding (learning) and retention (delayed recall and recognition), executive function
processes, language production, attention, visuospatial skills, and processing speed. The
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patterns and profiles attained from testing aid in a differential diagnosis between the
underlying pathologies (Karantzoulis & Galvin, 2011; Ramirez-Gomez et al., 2017;
Ramlall et al., 2014; Smith & Bondi, 2013; Stephan et al., 2017).
Normal aging individuals have no deficits on psychometric test performance
relative to their age-matched peers, whereas individuals “at risk” for dementia may have
borderline or impaired cognitive function in one or more areas of cognition when
compared to age-matched peers. Ideally, more than one measure is used in each domain so
that evidence converges to illuminate the relationship between tests intended to assess
similar constructs. This also helps assure that discriminant evidence between measures
intended to measure different constructs are also accurate. Educational and psychological
testing methods are some of the most significant and vital contributions of the behavioral
sciences to society (AERA, APA & NCME, 2014). The procedures for neuropsychological testing and data collection are highly operationalized and demonstrate
strong reliability (Ramirez-Gomez et al., 2017; Smith & Bondi, 2013).
Tests that are valid for their intended purposes provide substantial benefits
for test takers and test users…proper use can result in better decisions
about individuals and programs than would result without their use... The
improper use of tests, on the other hand, can cause considerable harm to
test takers and other parties affected by test-based decisions. (AERA, APA
& NCME, 2014, p.1)
A primary consideration in developing and evaluating tests is validity, an
accumulation of evidence that scientifically supports that the test measures the construct
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it is intended to measure. The validity and reliability of testing methods are the
foundation for accurate assessment (AERA, APA & NCME, 2014; Heaton et al., 2004).
The first empirical paper published in the Journal of Applied Psychology in 1917 was a
validation study by Terman and his colleagues (Cortina et al., 2017). The process of
validation deliberates arguments both for and against the intended interpretation of the
test scores relevant to their proposed use (AERA, APA & NCME, 2014). The validation
process is continual, constantly evolving as new data is gathered, and often necessitates
revisions to accommodate the latest articulated evidence (Wilkenson & Robertson, 2006).
The proposed study is a concurrent study, particularly useful for psychodiagnostic tests
(AERA, APA & NCME, 2014). It also continues the validation process of the measures
being used and may provide evidence to refine and reevaluate the utility of the tests and
their interpretations for use in an aging population.
Smith and Bondi (2013) asserted that NP measures are essential in clinical and
research efforts focused on neurodegenerative disease and defined five roles for such
measurements in preclinical and clinical dementia populations. First, NP measures serve
as biomarkers because they are highly operationalized and help distinguish between
underlying pathologies (Smith & Bondi, 2013). The FDA’s requirement that cognitive
measures must be included as a co-primary outcome in secondary prevention studies
solidified NP measures in this key role (Smith & Bondi, 2013). Second, they serve as
predictors for the development of AD and other dementias; they detect the clinical
manifestations of neurodegenerative disorders, so they should also predict their future
development (Smith & Bondi, 2013).
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Third, measures can dynamically capture countervailing influences on disease trajectory,
studies suggested that memory function does not decline at an even rate but goes through
periods of stabilization that may reflect biological and psychological compensatory
mechanisms such as the mediating and moderating factors of compensatory strategies or
cognitive reserve (Smith & Bondi, 2013). Fourth, NP measures are proxies for important
functional deficits; patients may be unreliable reporters of their own functional , so the
measures serve to estimate functional impairment which helps family members determine
what matters most, because it identifies when their loved one is no longer safe living
independently (Smith & Bondi, 2013). Finally, NP measure can provide insights into
interventional targets (Smith & Bondi, 2013). Just as important as identifying impaired
cognitive domains, measurements also have the ability to identify cognitive domains with
preserved strengths. Cognitive rehabilitation services can capitalize on an individual’s
residual strengths in order to compensate for weaker areas. These five functions demand
that the NP measures contain the optimal sensitivity and specificity for their intended
purpose.
A test that is sensitive to detecting a neurodegenerative disease like AD must have
a high probability that patients with AD score in the abnormal range, while higher
specificity assures that patients without dementia will score within normal range. Smith
and Bondi (2013) argued that positive predictive value rather than sensitivity, is
statistically more relevant to a diagnostic situation, and enhancements to specificity are
more important for this purpose. The use of norms is assumed to enhance specificity.
Researchers argue that aging is the major risk factor for dementia, therefor it undermines
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the sensitivity of NP measures to control for age (Hessler et al., 2014; Holtzer et al.,
2008; Malek-Ahmadi et al., 2015; O’Connell & Tuokko, 2010; Quaranta et al., 2016).
The current study will obtain empirical evidence and conduct logical analyses to evaluate
the proposition that age- and education-corrected norms may not universally improve
utility of testing measures in an aging population.
Norm-Referenced Interpretation in Neuropsychological Assessment
Educational and psychological testing theory assumes the concept of an “ideal” or
“normal” level of functioning against which the test taker’s performance can be
compared. Therefore, the most fundamental level of interpretation is the participant’s
performance in relation to the general population as established by a standardized sample
to derive normative scores (AERA, APA & NCME, 2014; Heaton et al., 2004). Raw
scores, simply the number of items correct on any given test, are thought to be of little
use because tests vary in difficulty and the number of items they contain, making it
difficult to make meaningful comparisons to other scores (AERA, APA & NCME, 2014;
Bryant & Brown, 1984; Schoenberg & Scott, 2011). Therefore, derived scores, a
statistical concept illustrating the participant’s exact position relative to individuals in the
normative group, has become a far more meaningful and significant metric. Norms
provide a point of reference that make raw scores valuable by allowing interpretations
that indicate if the individual’s performance is typical for the normative group. They also
allow for comparison of performance across various tests, track change or progress across
time, and diagnose strengths and weaknesses (Bryant & Brown, 1984; AERA, APA &
NCME, 2014; Schoenberg & Scott, 2011). Thus, norm-referenced interpretation has
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become gospel in testing theory (Quaranta et al., 2016). One of the fundamental
principles relevant to norming is the selection of the appropriate comparison group for
the tests being used.
At a most basic level, a normative sample is taken from the population that is
thought to be large enough to represent the current U.S. population, and sufficient enough
to be proportional across certain demographic characteristics such as sex, age, and level
of education, geographic region, and race or ethnicity. The mean score becomes the
average and expected level of performance for age and education. High scores are
classified in terms of being “high average”, “superior”, and “very superior”, while low
scores are described in terms of “low average”, “weak/mildly to moderately impaired”,
and “exceptionally weak/severely impaired”. The use of demographically corrected
normative scores is recommended for most diagnostic purposes. Yet, despite the quest to
achieve a fair representation in a normative sample, researchers established that there are
times when it may be advantageous to develop norms based on the performance of
individuals in a specific subpopulations; especially if the mean of the subgroup is 1 to 1½
SD away from the mean of the normative group, or when test performance is tied to a
specific therapy or treatment (Bryant & Brown, 1984; Hessler et al., 2014; Holtzer et al.,
2008; Malek-Ahmadi et al., 2015; O’Connell & Tuokko, 2010; Svinicki & Tombari,
1981). This study examines whether late adulthood, a time of exponentially increased risk
for cognitive impairment, may be one of the exceptions to the standard practice of using
an age- and education-corrected normative system.
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Methods of Norming
Both educational and psychological testing assume a “normal” level of functioning,
which is traditionally established by the mean test performance in the standardization
sample. The most fundamental interpretation of an individual’s performance is their
standing in relation to the general population. When the individual’s raw score is compared
to the distribution of scores across the sample population, it becomes a snapshot of where
they fall in that distribution. This gives clinicians and researches a uniform frame of
reference to determine the individual’s relative position within the context of the larger
population. Understanding the principles relative to developing norms is imperative for the
test user as “psychological test norms are in no sense absolute, universal, or permanent”
(Anastasi & Urbina, 1997, p. 68).
The main consideration in traditional norming methods is representativeness of
the standardization sample to the general population, but it is equally important that the
sample represent the population using the test (Anastasi & Urbina, 1997). Data should be
collected at multiple sites that represent different geographic regions of the U.S. The
advantage of traditional norming is its simplicity, but the greatest disadvantage is that
separate norm groups must be defined arbitrarily for continuous covariates like age and
as a result can change an interpretation of an individual’s test performance; a corrective
measure would be to define more categories, but the smaller sample size produces less
precise norms (Oosterhuis, et al., 2016). Zachary and Gorsuch (1985) introduced linear
regression to avoid categorizing continuous covariates. According to Oosterhuis et al.
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(2016) regression-based norming, which requires a smaller sample size but claims
equally precise norms is gaining in popularity.
It has been established that participants should be screened and excluded for
characteristics that might interfere with their performance such as sensory impairment,
brain impairing medications, or a medical history that includes stoke, epilepsy, or any
other neurological issues that affect cognition (White & Stern, 2003), but in an aging
population this is a difficult task. Robust norms, norms that follow the normative cohort
for a length of time removing anyone who develops dementia and keeping only those
who remain dementia free, may have more clinical utility than conventional norms when
dealing with an aging population (Holtzer et al., 2008). Hassenstab et al. (2016) found
that removing preclinical participants from normative samples yielded higher means and
less variability on episodic memory, visuospatial ability, and executive function measures
reducing age-affects, but provided no substantive benefit for diagnostic classification.
However, the considerable investment of resources needed to establish robust norms
leaves researchers looking for alternative methods to estimate the prevalence of
preclinical cases and consequentially adjust interpretation guidelines for cognitive testing.
Norm-Referenced Interpretation in MCI and Dementia
Norms are assumed to enhance specificity, the probability that a person without
dementia will have normal test scores. But because age is the number one risk factor for
dementia, researchers currently debate the use of norms in an aging population arguing
that norms reduce the sensitivity of the test scores to abnormal cognitive impairment
(Hessler et al., 2014; O’Connell & Tuokko, 2010; Quaranta et al., 2016). There are
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several reasons stated why this may be true. It is noted in the literature that norms
become less accurate as time between publication and use increases due to changes in
demographics and socioeconomic factors that modify the composition of the reference
population (Quaranta et al., 2016). It is also argued that individuals in the normative
sample population for age corrected norms may already be transitioning into dementia
and contaminating the norms by lowering the mean performance and increasing the
variability in cross-sectional samples (Holtzer et al., 2008). Late adulthood is also a time
when brain impairing maintenance medications are routinely prescribed to manage
chronic health conditions. Age correction is also thought to decrease the sensitivity of
measures because norms become more forgiving and tolerant of errors as age increases,
possibly decreasing the sensitivity of the tests to cognitive impairment and
underestimating the risk of dementia in our aging population (Smith & Bondi, 2013).
Optimal demographic correction as determined via the analyses in this study could result
in better diagnostic performance when differentiating normal controls from individuals
with dementia when employing cognitive testing.
Summary
It is recognized that symptoms of dementia may not appear for 20 years or more
after brain changes start to occur (Jack et al., 2015; Ritchie et al., 2015; Rockwood et al.,
2014; Smith & Bondi, 2013; Sperling et al., 2011; Sutphen et al., 2015; Ward et al.,
2013). Research is only beginning to address how many people may be in preclinical
stages of dementia or have MCI due to neurodegenerative diseases (AA, 2018) and these
individuals are included in the standard norms which influence a diagnostic outcome
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when employing a NP testing perspective. Smith and Bondi (2013) asserted the number
of patients that can be helped through neuropsychology is only increasing and the ability
to differentiate between normal aging, dementia, and the phase between the two, accepted
as MCI, has emerged as a primary focus of research.
Psychometric measures are the necessary tools that provide the data needed to
distinguish between normal aging and a neurodegenerative process (Smith & Bondi,
2013). As there is no single measure for dementia, the continued validation of current
measures to optimize their ability to differentiate between normal cognitive aging and a
neurodegenerative disease process is paramount. There is no cure for AD and the race
against the clock continues to inspire researchers to search for new ways to diagnose the
condition earlier and more accurately. Treatments and interventions must be administered
as early as possible if there is any hope of changing the course of the disease. Researchers
argue that outcome studies using comprehensive actuarial methods to examine the
patterns and profiles of NP dysfunctions are needed to move the field forward (Bondi et
al., 2014; Malek-Ahmadi et al., 2015, Smith & Bondi, 2013). The current study aims to
clarify the current debate over which normative method is most diagnostically accurate.
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Chapter 3: Methodology
The following methodology was review and approved by the Walden University
IRB, approval number 01-21-20-0529160. The overarching purpose of this study was to
investigate the impact of demographic corrections on the diagnostic validity of cognitive
tests in differentiating between normal cognitive aging and dementia. The standard
practice of demographically correcting raw test scores for age and education is widely
believed to universally improve the scores’ ability to detect cognitive impairment for all
age groups. However, there is a debate in the literature about the use of demographically
corrected scores in our aging population because the norms for older individuals may be
tainted by individuals with preclinical AD and thus underestimate the presence of
cognitive impairments. Consequently, it is not clear how to best use normative data in
dementia evaluations. This section is an exposition of the data and the analytic strategies
that will be used for this investigation.
First, the methodology and rationale is introduced along with a brief review of
how clinicians determine the presence or absence of dementia. Next, participant selection
procedures, recruiting strategies, and data collection techniques designed to minimize
threats to internal validity are addressed. The primary variables involved in the analysis
are presented, and the manner in which demographic corrections were applied and the
creation of aggregate cognitive composite scores from individual tests follows. The data
sources are thoroughly explained, including a review of the reliability and validity of the
tests taken from the most recent version of the UDS-3 NAB, with special attention paid to
the CDR-SB the primary criterion measure in the study. Subsequently the detailed data
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analysis plan that was used to investigate primary study hypotheses (including
assumption testing and regression diagnostics that protect against threats to internal and
external validity) are presented. Finally, a priori power analysis for tests of the overall
models was generated, and the regression coefficients are disclosed.
Hierarchical multiple linear regression was used to investigate the strength of the
relationship between the patient’s test scores (scored 4 different ways) and the patient’s
clinical dementia severity rating. Because the order of entry into the hierarchical multiple
linear regression model can have great impact on the results, the order of variable entry
was defined a priori, which avoided pitfalls inherent in methods such as stepwise
regression and will promoted better generalization as opposed to overfitting of sample
data (Harrell, 2001; Roa, 2003). Comparison of the R2 and AIC values of the various
regression equations clarified the extent to which the raw scores, or the various types of
demographic corrections (e.g., age, education, age and education) influenced the ability
of cognitive tests to detect meaningful variation functional changes due to cognitive loss
in dementia and MCI. While this cannot be explicitly tested for significance because
there are no universally accepted means for quantitatively comparing non-nested models,
it was one of the more important features of this study. Differences in R2 and AIC values
of the various regression models allowed for quantitative analysis of model differences,
albeit not with a specific statistical test.
Determining the Presence or Absence of Dementia
The primary difference between dementia and MCI is the extent to which the
cognitive decline influences the individual’s day-to-day functioning (APA, 2013;
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McKhann et al, 2011). MCI requires an objectively determined decline in cognitive
function as evidenced by mental status screening or formal NP testing in the setting of
relatively well-preserved day-to-day functioning (APA, 2013; Albert et al., 2011).
Dementia by definition requires significant functional impairment that represents a
decline from the individual’s previously higher level of functioning (APA, 2013;
McKhann et al, 2011). Heuristically and in clinical practice, this is often defined as the
loss of ability to independently complete IADLs (e.g., driving, managing one’s finances,
self-managing medications, using the community, etc.) with an adequate performance
level. More formally, global staging instruments such as the CDR measure the extent to
which cognitive loss interferes with an individual’s ability to perform day-to-day
activities (Morris, 1997). The CDR measure represents the ultimate quantitative standard
for the presence or absence of dementia and thus serves as an optimal criterion for the
purposes of the present study.
Study Variables
The primary variables involved in the analyses presented below included the CDR
as an outcome measure, a global measure of dementia severity that has been
neuropathologically validated and is considered an international “gold-standard” for
ascertaining the presence or absence of dementia (Olde-Rikkert et al., 2011). The CDR
also allows clinicians to derive the CDR-SB by summing clinician ratings in the 6
different domains, which provides a more fine-grained, pseudo-continuous measure of
dementia severity. Published criteria derived from large clinical samples exist for
determining the presence or absence of dementia using either the global CDR score
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(Morris, 1993) or the CDR-SB (O’Bryant et al., 2008, 2010). Individuals with a CDR-SB
of 0 are considered “normal,” those with a CDR-SB of 0.5 - 2.5 are considered to have
“questionable impairment,” those with a CDR-SB of 3 - 4 are considered to have “very
mild dementia,” whereas individuals with a CDR-SB of 4.5 - 9.0 are considered to have
“mild dementia.” The predictor variables were derived from a subset of the tests from the
UDS-3 NAB. The memory domain was represented by Craft Story immediate and
delayed recall and Benson complex figure delayed recall. The executive function domain
was defined by verbal fluency (F & L) and the Trail Making Test B. The language
domain was defined by the Multilingual Naming Test (MINT) and semantic fluency
(Animals). And Digit Span Forward (DGF) and Digit Span Backward (DGB) backward
were used to define the attention domain. Additional clinical and demographic variables
needed to process the data, such as etiologic diagnosis, age, education, gender, and visit
number were also utilized
Participant Selection and Stratification
Most individuals with Alzheimer’s disease develop the condition later in life, but
Alzheimer’s can develop in a subset of individuals any time after the second decade of
life (Rossor et al., 2010). Classically, Alzheimer’s dementia is considered “early onset”
or “young onset” when it develops prior to age 65. While this threshold is somewhat
arbitrary, there is a large body of evidence suggesting that individuals with early-onset
AD often present with atypical forms of the illness and different cognitive profiles
characterized by more visuospatial disturbance, executive dysfunction, and higher rates
of behavioral or neuropsychiatric disturbance (Ossenkoppele et al., 2015). The primary
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goal of this study was to inform the clinical use of NP tests in the types of situations most
commonly encountered by professionals in clinical practice. Accordingly, all subjects
younger than 60 years of age were excluded from analysis in order to increase the
likelihood that the study sample was most reflective of typical presentations of AD.
Similarly, different dementia subtypes present with different degrees and types of
cognitive difficulties. For example, dementia due to Lewy body disease is classically
thought to present with early visuospatial and constructional impairments while memory
may remain preserved until well into the disease course (Karantzoulis & Galvin, 2011).
Inclusion of non-Alzheimer’s dementia may thus introduce phenotypic-related variability
that would obscure detection of subtle differences due to demographic factors.
Accordingly, only individuals with a primary etiologic diagnosis of AD were selected
from the data set for analysis. Dementia due to AD is a progressive condition and
individuals traverse several stages during the course of the illness. NP tests may be most
helpful in the earlier phases of disease (e.g., MCI, Mild Dementia), as patients become
too cognitively impaired to participate meaningfully in assessment as they transition from
mild to later stages of dementia. There is also a high likelihood that cognitive test data
from moderate to severely demented patients may be less reliable and thus less
meaningful than in individuals with milder forms of the disease (Weintraub et al., 2018b).
For example, attention, language, memory, and executive function test results may be
substantially influenced by general confusion, language comprehension problems,
difficulty appropriately engaging in the task, or other impairments that render cognitive
tests unreliable indicators of the processes they are purported to measure. Accordingly,
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individuals with a CDR-SB > 9 (i.e., moderate to severe dementia) were removed from
all analyses.
Creation of Cognitive Composites
Most studies addressing the effects of age and education correction on the
predictive validity of cognitive tests in dementia have focused on single test scores
(Sliwinski et al.,1996; Sliwinski et al., 1997) or heterogenous composite scores
representing multiple cognitive domains (Hessler et al., 2014). It is likely that age and
education correction influence different cognitive domains differently. For example,
processing speed invariably declines with increasing age (Eckert, 2010) whereas
crystallized abilities such as vocabulary or fund of knowledge remain stable or even
improve throughout senescence (Harada et al., 2013). A novel feature of the present study
was the creation of domain-specific cognitive composite scores for memory, executive
function, language, and attention that allowed for precise investigation of the extent to
which age and education affected the predictive validity of individual cognitive domains
using a hierarchical multiple linear regression analysis.
Creation of cognitive composites was also advantageous statistically. Composite
measures may be more sensitive to longitudinal cognitive changes in preclinical dementia
and more reliable than the measures from which they are derived (Riordan, 2017).
Cognitive composites also offer a better and more complete sampling of participant
cognitive abilities than do single cognitive test scores by virtue of their broader item
content. Models with fewer explanatory variables are also more desirable than complex
models due to enhanced interpretability (James et al., 2017). Such models also tend to
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demonstrate less variance across samples, which increases the likelihood that they will
generalize to new samples. Composite scores can generally be categorized as empirically
derived, theoretically derived, or some combination of these two methods (Weintraub et
al., 2018b). This project made use of a theoretically driven strategy that is grounded in
well-established principles of NP function and localization. The method used for
aggregation of tests within a domain has been widely used as exemplified by Donohue et
al. (2014) and involves first grouping tests into different cognitive domains, transforming
scores to the same metric (i.e., Z-scores), and then summing them to create aggregate
cognitive composite measures with similar psychometric properties and scales of
measurement. Theoretical groupings of the particular tests used in this study into
different cognitive domains (memory, executive function, language, and attention) are the
same as in Weintraub et al. (2018a).
Impairments in memory and executive functioning are highly characteristic of the
cognitive phenotype associated with typical presentations of AD (Karantzoulis & Galvin,
2011). Memory measures in particular have been shown to be some of the earliest
indicators decline, even in minimally symptomatic individuals (Weintraub et al., 2018b).
Tests in this domain included Craft Story immediate and delayed recall and the Benson
complex figure delayed recall. The executive function domain included verbal fluency (F
& L) and Trail Making Test B. Impairments in language including deficits in semantic
verbal fluency and visual object confrontation naming are also characteristic of AD
(Salmon & Bondi, 2009). This domain was constructed using the Multilingual Naming
Test (MINT) and semantic fluency (Animals). Individuals with AD may additionally
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show difficulties with attention and working memory, though these abilities are often
better preserved until later into the illness (Cherry et al., 2002). Digit Span Forward
(DGF) and Digit Span Backward (DGB) backward were used to create the attention
domain. Following transformation of raw scores into Z-scores using the various norming
methods described in the following section, Z-scores were summed across tests within a
given cognitive domain to create a composite score for each domain. These composite
scores served as the predictor variables in the series of hierarchical regression analyses.
Cognitive Test Scoring
Subjects’ raw test scores were analyzed before and after a series of demographic
corrections. Cognitive tests are scored on different metrics (i.e., seconds to completion as
opposed to number of words remembered) and thus must be transformed to a common
scale in order to facilitate comparison. Weintraub and colleagues (2018b) developed a
normative calculator for the UDS-NAB through fitting linear regression models to the
cognitive test data of 3602 cognitively normal participants over the age of 60.
Specifically, cognitive test scores were predicted using age, gender, education, and the
combination of these variables. These regression models can then be used to standardize
observed test scores, adjusting for the demographic variables of choice.
The intercepts of the regression models represent the mean performance of the overall
study sample holding age and education constant. The root mean squared error (RMSE)
represents the average squared difference between the observed scores and the predicted
scores, which can be used as a surrogate measure of the population standard deviation
(Weintraub et al., 2018b). To facilitate comparison between the models, the intercept,
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slope, and demographic variable regression weights from the full model incorporating
age, sex, and education will be utilized and thus, all analyses were corrected for gender.
To generate “raw scores,” subjects’ scores were first transformed into Z-scores by
generating predicted scores using each subjects’ actual gender, the average education and
age level of the overall sample, subtracting the predicted score for a participant from their
observed score, and then dividing by the RMSE of the model. There were no systematic
adjustments for age or education, allowing the variability of those factors to remain in the
model. To generate age-corrected scores, participant scores were transformed as above
but with an adjustment for age by multiplying the participant’s actual age by the
coefficient for age when generating the predicted scores. To generate education-corrected
scores, the same procedure was applied but with an adjustment for each participant’s
actual education level. To generate age- and education-corrected scores, subjects’ actual
age and education was used to generate predicted scores.
The National Alzheimer’s Coordinating Center Uniform Data Set 3
NACC was established by a division of National Institutes of Health. NACC’s
ultimate goal is to provide a comprehensive approach to research on AD (Besser, 2018).
To date, there are 39 present and past ADCs. In 2005, the ADCs began longitudinally
collecting demographic, clinical, NP, and diagnostic data on the original version of the
UDS (Morris et al., 2006). Version 2 was implemented in 2008, which represented a
minor update to data collection elements including several new forms, restructuring the
form logic, and adding a few NP test elements. The 3rd and most recent revision of the
Uniform Data Set (UDS-3) represents a major advance, including a fully updated NP test
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battery, additional supplemental data, and updated diagnostic criteria to reflect changes in
how dementia syndromes are classified in current clinical practice. Data collection with
the UDS-3 was implemented in March 2015. As of the most recent data freeze in March
2019 approximately 6, 266 individuals in the UDS 3 had completed the UDS-3 NAB.
Further details regarding the study sample are available at:
www.alz.washington.edu/WEB/UDS_NEUROonepage.pdf.
Each ADC enrolls subjects according to its own protocol. Subjects may come via
clinician referral, self-referral by the patient or family members, active recruitment
through community organizations, or by volunteering. In addition to patients with
dementia and mild cognitive impairment, most centers also enroll normal control
participants. As such, the NACC subjects are not a statistically representative sample of
the U.S. Population. They are best described as a referral-based or volunteer case series.
This renders UDS data inappropriate for studies of the prevalence or incidence of
dementia. UDS data are collected via standardized evaluation of subjects enrolled in the
ADCs. Data are generated using a standard order of administration for the NP tests,
collected by trained clinician and clinic personnel, and diagnosis is made by either a
consensus team of multiple practitioners or a single physician dependent upon the
individual ADCs protocol. Subjects are seen for an initial visit and followed
longitudinally with approximately annual visits until they can no longer participate or are
lost to follow up. The complete UDS data-collection protocol is available at
https://www.alz.washington.edu/WEB/qaqc_protocol.html.
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Clinical Dementia Rating
The CDR is a dementia severity rating that is clinician administered, structured
interview of a patient and a knowledgeable informant (often a family member) that can
be conducted by a physician, nurse, social worker, or other trained staff member (Morris,
1997). Following the interview, clinicians rate a patient’s functioning in the areas of
memory, orientation, judgment and problem solving, function at home and hobbies,
function in the community, and personal care. A global score can be calculated based on
published scoring rules and used as a gross summary measure of dementia severity, but
the CDR also allows clinicians to derive the CDR-SB which provides a more finegrained, pseudo-continuous measure of dementia severity. Published criteria derived
from large clinical samples exist for determining the presence or absence of dementia
using either the global CDR score (Morris, 1993) or the CDR-SB (O’Bryant et al., 2008,
2010). The CDR was developed by John Morris and colleagues at the Washington
University in St. Louis ADC in the 1980s (Hughes et al., 1982). It has since become the
dominant global staging measure used clinically, in research, and as a primary end point
in clinical trials. It has been translated into 14 different languages and was described as
the “best-evidenced” measure in a recent review on global dementia severity staging
measures (Olde-Rikkert et al., 2011). The CDR has been neuropathologically validated
and demonstrates predictive accuracy of 92% for the presence of Alzheimer’s pathology
in symptomatic individuals with AD (Storandt et al., 2006). Studies indicate high
interrater reliability for physicians and non-physicians applying the CDR (Williams et al.,
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2013). Accordingly, the CDR was an ideal criterion measure for the purposes of the
present study.
Craft Story 21
The trademark characteristic of AD is memory loss, so list learning and story
memory tasks are frequently used in the episodic memory evaluation for dementia. Craft
and colleagues designed a story recall test with multiple forms that achieved similar
psychometric properties to the Weschler Logical Memory test, immediate and delayed
recall conditions (Weintraub et al., 2018a). The complete set of stories consisted of 22
narratives that were originally tested on 13 healthy adults and 22 patients with
Alzheimer’s dementia and rated on the CDR as very mild, mild, moderate, and severe
(Craft et al., 1996). Participants listened to a brief story with 25 bits of information and
were asked to recall both immediately and after a 10-minute delay, receiving credit for
each bit of data that was recalled verbatim or accurately paraphrased. Validity was
determined by correlation with The Wechsler Memory Scale normative scores:
Pearson r’s between Logical Memory and paragraph recall scores were
0.73, p < 0.02 (immediate recall) and 0.84, p < 0.004 (delayed recall) for
normal adults and 0.76, p < 0.0002 (immediate recall) and 0.88, p < 0.0001
(delayed recall) for Alzheimer patients. Group mean and SD were nearly
identical. (Craft et al., 1996, p. 126)
When the Neuropsychology Work Group committee convened to make recommendations
for the UDS-NAB 3, their pilot study to determine the equivalence of the stories in
middle-aged and older adults determined that 3 of the stories offered the greatest
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relationship to the Logical Memory subtest of the Weschler Memory Scale and to each
other, with a single story chosen because of its applicability to a culturally diverse
population and “Craft Story 21” was adopted as the episodic memory measure for UDSNAB 3 (Weintraub et al., 2018a). In this study, the composite score for the memory
domain was composed of the scores from Craft Story 21 and the Benson Complex Figure
recall task.
Benson Complex Figure
Asking a patient to copy a figure is the most common method of assessing
visuospatial ability in dementia evaluations and having the patient recall the figure after a
delay is considered a measure of nonverbal memory. These tasks are new addition to the
UDS-NAB 3. Impairments in the visuospatial domain commonly appear in AD, bvFTD,
and DLB. Complex figure copy tasks like the Rey-Osterrieth Complex Figure are
influenced by visual spatial perception and attention, and also frontally mediated
executive skills like organization, strategic planning, and working memory (Possin,
Laluz, Alcantar, Miller & Kramer, 2011). The Rey Complex Figure Test was developed
by Rey in 1941 and has a long history in neuropsychology (Strauss et al., 2006). Internal
reliability was evaluated by split-half and alpha coefficients and achieved greater than .60
for copy trial, and greater than .80 for recall trial. Test-retest reliability examined (r = .76;
r = .89) for immediate copy and delayed recall respectively (Strauss et al., 2006). Validity
is also supported through independent correlational and factor analytic studies (Meyers &
Meyers, 1995). The Benson Figure is a simplified variation of the Rey-Osterrieth figure
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developed by Frank Benson (Possin et al., 2011) and was adopted as a measure of
visuospatial ability and memory recall in the UDS-3 NAB.
Phonemic Fluency
Verbal fluency tests assess the spontaneous production of individual words under
constrained conditions. Phonemic fluency tasks (“F” and “L”) are commonly used in
many NP batteries (Strauss et al., 2006). Originally developed as a measure of primal
mental abilities by Thurstone in 1938, his variant of the word fluency test showed
performance improved throughout childhood, peaked about age 30-39, and mildly
declined into old age in normal cognition. This pattern was confirmed by subsequent
research, and accumulating evidence showed that the test was highly useful for the
detection of dementia because it is heavily dependent on the integrity of executive
function (Strauss et al., 2006).
The letters F, A, and S are most commonly used, but C, F, and L are also used.
The examinee is given the specified letter, in this case F and L, and orally produces as
many words as possible in 1 minute. The total score is the sum of all correct words for
both letters. Alternate form reliability observed correlations among phonemic fluency
tasks high (.85 to .94) with differences between letter sets small (Strauss et al., 2006). For
a detailed discussion of letter equivalence across different versions see Borkowski,
Benton and Spreen (1967). Studies indicated test-retest correlations typically .70 or
higher for letter and fluency at both short (2 week) and long (5 year) intervals (Strauss et
al., 2006). Age and education corrected norms are published in manuals (Heaton et al.,
2004), and can be statistically computed (Mitrushina et al., 2005; Tombaugh et al., 1999).
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For the purpose of this study, verbal fluency F & L and TMT B were chosen as measures
of the executive function domain.
Trail Making Tests B
The adult version of the Trail Making Tests (TMT) measures processing speed in
people aged 15 to 89. Originally constructed in 1938 as a divided attention test, they were
part of the Army Individual Test Battery and adapted by Reitan in 1955 (Strauss et al.,
2006). Scoring is expressed in seconds required to complete the test with a maximum
time on TMT B set at 300 seconds. Performance is affected by age, education, and IQ;
with education becoming progressively more important with increasing age. Test-retest
reliability was high in healthy controls (r = .89) for TMT B; but not uniformly reliable in
clinical groups (r = .67 to r = .86); practice effects noted in healthy controls leveled off
after 5 administrations (Strauss et al., 2006). Alternate form reliability reported a
reliability coefficient of .92. Validity was demonstrated through correlations with other
measures of executive processing speed including the Category Test; Wisconsin Card
Sorting Test; Visual Search and Attention Test; Symbol Digit Modality Test; Paced
Serial Addition Test; and Letter Cancellation that were moderate to strong (.36 to .93)
with TMT B emerging as more sensitive to executive control (Strauss et al., 2006). Thus,
TMT B was chosen to be included in the composite measure of executive control
function.
The Multilingual Naming Test
Individuals with AD show deficits in naming speed and accuracy (dysnomia). The
Boston Naming Test is one of the most common measures of confrontation naming
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(Kaplan et al., 1983) and has been shown to discriminate well between cognitively
normal participants and those with dementia (Katsumata et al., 2015). The MINT was
specifically designed to be a culturally sensitive measure of picture naming for English,
Spanish, Mandarin Chinese, and Hebrew. Sixty-eight black-and-white line drawings,
selected from a variety of sources with translation equivalents in each different language,
are presented in increasing difficulty of order. Ivanova et al. (2013) found the MINT was
highly correlated with the BNT, ranging from r = .855 to r = .893, p < 0.001, and
suggested that it had more utility for diagnostic purposes as the BNT was biased in favor
of English. Ivanova et al. (2013) established that a 32-item subset of the MINT had
adequate sensitivity and provided superior clinical utility because of its contextual
diversity to detect naming impairments in AD and controls.
The NP Work Group replaced the Boston Naming Test (BNT) with the MINT for the
UDS-NAB 3 (Weintraub et al., 2018a). This study used the MINT and Animal Fluency
as the measures for the Language domain.
Animal Fluency
The most common semantic fluency test requires an individual to name as many
animals as possible in 1-minute, other categories such as fruits and vegetables or “things
to wear” are also used (Strauss et al., 2006). Norms were derived from large samples of
participants that ranged in age from 20 to 101 years of age depending on the study; (n =
1148) in Heaton et al. (2004); (n = 2843) in Mitrushina et al. (2005) and (n = 735) in
Tombaugh et al. (1999) to name just a few. Tombaugh et al. (1999) found the degree of
internal consistency high (r = .83) and test-retest reliability coefficient of .74 after a 5-
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year interval in elderly individuals. Studies showed test-retest correlations were typically
.70 or higher for semantic fluency at both short (2 week) and long (5 year) intervals
(Strauss et al., 2006). Like phonemic fluency tasks, age and education corrected norms
are located in published manuals (e.g., Heaton et al., 2004) and can be statistically
computed (Mitrushina et al., 2005; Tombaugh et al., 1999).
Digits Forward and Digits Backward
DGF assess attentional capacity using auditory digit repetition, a common method
used in most existing tests for this purpose. DGB requires the examinee to reverse orally
presented digits as a measure for both attentional capacity and working memory. The
number strings are administered up to failure of two trials at the same length with points
earned for each completed sequence and, in some cases, a note for the longest digit span
completed. Digit span tasks are modeled after the Weschler Memory Scale III (WMS),
which was originally designed to assess auditory attention and working memory (Strauss,
2006). The number spans for the UDS-NAB 3 were randomly generated with the
restriction that no digit would be adjacent to the next higher or lower digit, and efforts
made to avoid recognizable sequences such as common area codes (Weintraub et al.,
2018a). Digit span generalizability coefficients to the WMS were high (.80 to .89), and
while ‘clinical lore’ espouses that DGB is more demanding of working memory than
DGF and more sensitive to advancing age and neurodegenerative conditions, the most
recent findings suggest that both DGF and DGB are affected equally as one ages,
although large discrepancies between the two tasks may point to a deficiency in working
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memory (Strauss et al., 2006). DGF and DGB served as our measures of the attention
domain.
Data Analysis Plan
The following section describes the analytic strategies that will be used to answer
the primary study hypothesis, data cleaning (e.g., handling of outliers and missing
values), construction of hierarchical linear regressions to test primary study hypotheses,
and an a priori power analysis. Prior to that discussion, it may be helpful to restate the
series of regression analyses that are planned, and the primary study hypothesis and subhypotheses. This study involved predicting the CDR-SB score by a combination of
cognitive composite scores derived from cognitive tests scored using 4 different methods
of demographic correction (i.e., no correction, age correction, education correction, age
and education correction). The following prototype model was built 4 different times
(once for each of the norming methods) and then those models were compared using R2
and AIC values: CDR-SB scores =
β1Memory and Learning + β2 Executive Function + β3 Language + β4 Attention
Four sets of regressions were used to examine:
1. The relationship between CDR-SB and the “raw” (i.e., corrected for gender
only) cognitive composite scores.
2. The relationship between the CDR-SB and cognitive composite scores derived
from age corrected test data.
3. The relationship between the CDR-SB and cognitive composite scores derived
from education corrected test data.
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4. The relationship between the CDR-SB and cognitive composite scores derived
from age and education corrected test data.
There was one model for each norming method as specified above, so
determining which model was “best” required comparing the merits of the various
models. This represented a statistical conundrum, because the models were built using
different data (data subject to different norming methods) and as such are “non-nested”
models. In the context of least squares regression, nested models are easily testable for
differences at a given significance level but there are no universally agreed upon methods
for comparing non-nested models. In practice, various parameters such as a model’s R2
value and AIC are typically used for model selection purposes in lieu of significance
tests. For consideration, some authors have convincingly argued that null hypothesis
testing itself is undesirable and gives a false sense of precision when none is warranted
and as such, the lack of significance testing in this project is not viewed as a particular
shortcoming (Harrel, 2001).
R2 values represent the total amount of variability in the criterion variable, in this
study the CDR-SB, accounted for by the predictor variables, in this case the cognitive
composite scores (Field, 2013). Thus, models with a higher R2 value are desirable and
indicate that the predictor variables are capturing more variation in the criterion of
interest than models with a lower R2 value. Cohen (1988) has set conventions for
interpreting R2 values that are used widely in the social sciences, with R2 = .02 considered
a small effect, R2 = .25 considered a medium effect, and R2 = .40 or greater considered to
be a large effect. Thus, there would be clear and meaningful differences between the
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models if the R2 values associated with the different models fell into different effect size
categorizations. For example, if the R2 value in equation 2 was moderate (R2 > .25) and
the R2 value in equation 1 was strong (R2 > .4), then model 1 is clearly superior to model
2. Differences that are smaller in magnitude may suggest the superiority of one model
versus another model, but there are no universally accepted criteria for determining the
incremental difference required to make a clinically significant contribution to clinical
practice. In the context of dementia evaluation, it can be argued that any increase in R2
value that might lead to greater diagnostic accuracy is desirable and may be of practical
significance at a population level.
AIC was developed by Hirotogu Akaike in 1974 (Akaike, 1974) and is typically
employed in logistic regression but can also be computed for least squares regression.
This parameter is used commonly for model selection and considers both a model’s
overall fit and its parsimony. While AIC is often used to compare nested models,
Akaike’s work makes no statement that models must be nested, and thus this statistic is
often used to compare non-nested models. One calculates the lowest AIC value of all
models being considered and then evaluates the change in AIC between different models
(the delta AIC). According to Burnham and Anderson (2004), models having a delta AIC
less than or equal to 2 have substantial support and are comparable to the model with the
minimum AIC value. Those in which 4 ≤ delta AIC ≤ 7 can be said to have considerably
less support, and those where delta AIC > 10 have essentially no support. Therefore, the
models above can be compared semi-quantitatively using their AIC values with the
model having the lowest AIC value being the most desirable.
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Primary Study Hypothesis
H1: Age and education correction increase the extent to which NP tests are able to
capture functional decline due to cognitive loss in dementia. This will be tested by
comparing R2 and AIC values from regression equation 1 with regression equation 4.
H01: Age and education correction decrease or have no effect on the extent to which NP
tests are able to capture functional decline due to cognitive loss in dementia.
H2: Age correction decreases the extent to which NP tests are able to capture functional
decline due to cognitive loss in dementia. This will be tested by comparing R2 and AIC
values from regression equation 1 with regression equation 2.
H02: Age correction increases or has no effect on the extent to which NP tests are able to
capture functional decline due to cognitive loss in dementia.
H3: Education correction increases the extent to which NP tests are able to capture
functional decline due to cognitive loss in dementia. This will be tested by comparing R2
and AIC values from regression equation 1 with regression equation 3.
H03: Education correction decreases or has no effect on the extent to which NP tests are
able to capture functional decline due to cognitive loss in dementia.
Optimal demographic correction as determined by the analyses above may result in better
diagnostic performance when differentiating normal controls from individuals with
dementia. Comparison of the R2 and AIC values of the various regression equations
presented above will clarify the extent to which various types of demographic correction
influence the ability of cognitive tests to detect meaningful variation in dementia severity.
While the above hypotheses are not associated with significance levels, R2 values and
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AIC values are commonly used to compare non-nested models and allow the important
research questions above to be answered quantitatively.
Data Preparation
The plan was to identify missing values and either exclude them on a case-wise
basis during analyses or replace them with the group-wise mean value (i.e., a missing
value for a patient with mild dementia would be replaced using the mean of that variable
for individuals with mild dementia). The strategy used depended on the number of
missing data points and other specific data characteristics that were not known prior to
receiving the data set. Primary tests of study hypotheses may further benefit from
exclusion of outliers and transformation of poorly behaved variables that deviate
markedly from normality. It should be noted that linear regression does not explicitly
require multivariate normality (Allison, 1999). As with most parametric models however,
relative normality prior to model fitting may aid in model stability, generalization, and
avoiding violations of other assumptions downstream (Tabachnick & Fidell, 2012).
To assess normality, histograms and Q-Q plots were constructed for each of the
cognitive tests for visual inspection (see appendix). Skew and kurtosis values were
calculated. In general, skew and kurtosis values < 1 are considered acceptable,
particularly given that multiple linear regression does not require normally distributed
variables (George & Mallery, 2016). Parametric methods such as the KomolgorovSmirnoff test were not appropriate for the present study because with the large sample
size, they would be overpowered and likely detect tiny departures from normality.
Similarly, it was also inadvisable to perform statistical tests of skew and kurtosis values
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by dividing them by their standard errors and then comparing them to a Z-score
distribution (Field, 2013). Data transformations were considered and applied as needed
with the caveat that model interpretability was a primary concern and thus variable
transformation was avoided if at all possible, particularly for the CDR-SB. Univariate
outliers were identified through the use of Boxplots, with values plus or minus 3 times
the interquartile range of a variable screened as potential outliers (Field, 2013).
Multivariate outliers were identified within the regression analyses through several
different methods described below.
Statistical Analytic Strategies
Prior to modeling, the data was described by calculating descriptive statistics
including the mean, standard deviation, and range of all study variables. The
intercorrelations of the cognitive test scores, age, education, and the CDR-SB were
calculated for each different norming method using bivariate Pearson correlations. These
correlations provided a direct measure of the strength of relationship between a given
cognitive test and the criterion measure of interest. These bivariate correlations aided in
the interpretation of the hierarchical linear regression analyses for testing primary study
hypotheses, helped to detect suppression, and served as a measure of variable importance
(Nathans et al., 2012). Following descriptive statistics and analysis of intercorrelations
between tests, the primary study hypotheses was tested using least squares hierarchical
multiple linear regression. This analytic technique is appropriate when one wishes to
examine the magnitude of association between a set of continuous predictor variables and
a continuous outcome variable (Field, 2013).
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The order of variable entry was defined a priori, which avoided the pitfalls
inherent in methods such as stepwise regression and promoted better generalization as
opposed to overfitting of sample data (Harrell, 2001). The cognitive composite scores
were entered in the following order in a block wise fashion using an alpha of 0.5 to enter
the model: memory, executive functioning, language, and attention. It was hypothesized
that memory and executive function would be the most important predictors in the model
irrespective of norming method followed by language, then attention. The models were
evaluated based on R2 values and adjusted R2. Models were compared by examining R2
differences between models and AIC differences. The importance of individual cognitive
domains were evaluated by examining R2 change, standardized regression weights
associated with each cognitive domain, and significance of terms in the final models. The
model construction strategy allowed for a precise determination of the different
proportions of variance accounted for by each cognitive domain and how the magnitude
of those relationships was affected by demographic correction.
Regression requires several assumptions: linearity of the relationship between
predictor and criterion variables, absence of multicollinearity, absence of outliers
amongst the independent and dependent variables, independence of errors, and
homoscedasticity (Tabachnick & Fiddell, 2012). Linearity was examined visually using
scatterplots and bivariate Pearson correlations described above. Multicollinearity was
addressed a priori by design, through creating homogeneous cognitive composites that
were relatively distinct from one another by virtue of their item content. Bivariate
Pearson correlations between the test variables allowed for quantitative evaluation of any
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multicollinearity between variables. In general, variables with correlations above 0.7 –
0.8 should not be used together in a regression equation (Allison, 1999). Variance
Inflation Factor (VIF) and tolerance values calculated as a result of the regressions
complemented these a priori methods of detecting multicollinearity. In general, VIF
above 10 and Tolerance values below 0.2 are considered as representing possible
problems (Field, 2013). Outliers and influential data points were evaluated using
regression diagnostics.
In a multiple regression context, outliers can be defined as points that differ
substantially from the main trend of the data (Field, 2013). Examination of standardized
and studentized residuals following model fitting was used to identify such points which
were further inspected for possible removal. Single data points with standardized
residuals above or below 3.29 were considered for removal, as values this high are
unlikely to occur based on chance (Field, 2013). The proportion of cases with
standardized residuals greater or less than 1.96 was also examined, because 95% of data
points should fall within these values in a well-fitting model. Multivariate outliers were
also evaluated by calculating their distance from the group centroid via Mahalanobis
distance, which is distributed as a Chi-square and can be evaluated at p < .001 to detect
multivariate outliers (Meyers et al., 2016).
Outlying data points may not be a large concern if they are not overly influential
on the overall model. To assess influence, leverage values were examined. Leverage
gauges the influence of the observed value of a case on a particular variable over the
predicted values of a regression solution. The average expected leverage is defined as
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(k+1/n) with cutoff values around 3 times the average leverage value typically considered
as indicative of points with undue influence (Pituch & Stevens, 2015). This statistic was
complemented by calculation of studentized deleted residuals, which represented the
difference between the prediction of an observed value when it is and when it is not
included in the model divided by its standard deviation (Field, 2013). Influence on the
overall model was evaluated using Cook’s distance, with values greater than 1 potentially
indicating cause for concern (Cook & Weisberg, 1982).
Independence of errors or lack of autocorrelation amongst residuals was assessed
using the Durbin-Watson statistic which tested for serial correlations between adjacent
residuals. This statistic ranges from 0 to 4, with values greater than 2 implying negative
correlation and below 2 implying positive correlation. Rule of thumb suggested by Field
(2013) for evaluating this statistic are that values less than 1 or greater than 3 are
indicative of a possible problem. Homoscedasticity was evaluated by plotting
standardized residuals vs. standardized predicted values, which should ideally assume a
random pattern. Funnel shaped plots may suggest heteroscedasticity and a curved
appearance may indicate departures from normality (Field, 2013). Histograms of residual
values and normal p-p plots were also calculated to examine normality of residuals.
Power Analysis
Power for multiple regression includes tests of the overall model being
significantly different than 0, tests of R2 increase at each step in variable entry, and tests
for the significance of individual regression coefficients. G*Power 3.1.9.4 was used to
examine power for each of these tests assuming a moderate effect size (f2 = 0.15) and α =
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.05 at the desired power level of 0.8, as recommended by Cohen (1988) (Faul et al.,
2007). A total sample size of n = 85 was required to achieve power of 0.803 for tests of
the R2 deviation from 0 and the same sample size was required for tests of R2 increase. A
total sample of 55 was required for tests of model coefficients.
Summary
The current investigation examined the impact of demographic correction on the
diagnostic validity of cognitive tests in the service of differentiating between normal
cognitive aging, MCI, and dementia. The proposed study challenges the standard practice
of demographic correction thought to universally improve cognitive testing instruments’
sensitivity to impairment. The NACC appointed a specific task force to choose the set of
measures that are freely available and have adequate discriminatory powers to encourage
uniform data collection strategies and collaboration between researchers. The resulting
data set, the UDS Version 3, was the focus of the current study because of its size and
diversity. It contains healthy control participants as well as those meeting the diagnostic
criteria for MCI and Alzheimer’s dementia. The results of this study may not only tip the
debate towards an optimum scoring method to detect the earliest stages of degenerative
cognitive impairment, but it may also advise the illusive search for a set of cognitive
biomarkers that distinguish individuals who are experiencing the effects of normal aging
from those in the process of developing a neurodegenerative disease. The earlier and more
accurately we can diagnose Alzheimer’s, the greater chance we have of altering the
disease trajectory, potentially improving the future for the many individuals that are yet to
be diagnosed and other stakeholders.
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Chapter 4: Results
The purpose of the present study was to investigate the impact of demographic
corrections on the diagnostic validity of cognitive tests when differentiating between
normal cognitive aging and AD dementia. The standard practice of demographically
correcting raw test scores for age and education is widely believed to universally improve
the scores’ sensitivity to detecting cognitive impairment for all age groups but has been
challenged by researchers who believe that uncorrected scores may be more sensitive for
detecting impairment in the aging population (Hassenstab et al., 2016; Hessler et al.,
2014; Holtzer et al., 2008; O’Connell & Tuokko, 2010; Wyman-Chick et al., 2018) .
Hierarchical multiple linear regression was used to predict the outcome variable, the
CDR-SB scores, by a combination of cognitive composite scores derived from cognitive
tests scored using 4 different methods of demographic correction.
The cognitive domain composite scores for memory, executive function,
language, and attention were the predictor variables. The composite construction strategy
was based on the same theoretical grouping of tests used in the work of Weintraub et al.
(2018a). This theoretically driven strategy is well grounded in established principles of
NP function and localization. Weintraub and colleagues (2018b) developed a normative
calculator for the UDS-NAB using test data of 3602 cognitively normal participants over
the age of 60. This model was used to standardize the test scores and adjust for the
various demographic corrections that were compared in the regression analysis. The
composite score for the memory domain (MEMO) was composed of the scores from 2
tests, Craft Story 21 and the Benson Complex Figure recall task. The executive function
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domain (EXEC) was constructed from verbal fluency F & L and TMT B tests. The
language domain (LANG) was derived from the MINT and Animal Fluency measures.
And the attention domain composite score (ATTN) was composed of DGF and DGB
tests. For a full discussion of the reliability and validity of each individual NP test, see
chapter 3. Cognitive composites offer a more complete sampling of cognitive abilities
than a single cognitive test by virtue of broader item content and are advantageous
statistically as they can be more sensitive to cognitive changes in preclinical dementia
therefore more reliable than the single measures from which they were derived. These 4
domains were chosen because models with fewer explanatory variables are more
desirable than complex models due to enhanced interpretability (James et al., 2017). For
more details on how each of the demographic scores were computed see the full
discussion in chapter 3 under the subheadings “Cognitive Test Scoring” and “Creation of
Cognitive Composites”.
The order of entry into hierarchical regression models was defined a priori.
Memory measures have been shown to be the earliest indicators of decline in AD even in
minimally symptomatic individuals, and executive function impairment usually follows
(Karantzoulis & Galvin, 2011). Deficits in language functioning, including semantic
verbal fluency and visual object confrontation are also characteristic of AD (Salmon &
Bondi, 2009). Individuals with AD may also exhibit impairment with attention and
working memory though these abilities may be well preserved until later into the illness
(Cherry et al., 2002). The following prototype model was built 4 different times, once for
each norming method:
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CDR-SB scores = β1MEMO + β2 EXEC + β3 LANG + β4 ATTN
The first model was corrected for gender only (G) and considered the raw scores for the
purpose of the analysis. The second model was age corrected only (GA). The third model
was education corrected only (GE). The fourth model was corrected with a combination
of both age and education (GEA). Therefore, the abbreviated combination of MEMO_G,
is the score for the memory composite score corrected only for gender (raw score), while
MEMO_GEA is the memory composite score corrected for gender, education, and age.
Four sets of regressions will be used to examine:
1. The relationship between CDR-SB and the G cognitive composite scores.
2. The relationship between the CDR-SB and GA cognitive composite scores.
3. The relationship between the CDR-SB and GE cognitive composite scores.
4. The relationship between the CDR-SB and GEA cognitive composite scores.
Models were compared by examining R2 differences between the models and AIC
values. This strategy clarified the extent to which the raw scores and various
demographic corrections influenced the ability of the cognitive tests to detect meaningful
variation in functional changes due to cognitive loss from AD dementia. The importance
of individual cognitive domains was evaluated by examining R2 change, standardized
regression weights associated with each cognitive domain, and significance of terms in
the final models. It also allowed for the precise determination of the different proportions
of variance accounted for by each cognitive domain with each norming method.
Determining which model was “best” required comparing the merits of the various
models because there was one model for each norming method as specified above.
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The overarching research question was how demographic corrections affected the
strength of the relationship between cognitive test scores and CDR-SB. The primary
study hypothesis was that age and education correction would increase the extent to
which NP test scores were able to capture functional decline due to cognitive loss in
dementia. There were also 2 subhypotheses 1) age correction alone would decrease the
extent to which NP tests were able to capture functional decline due to cognitive loss in
dementia, and 2) education correction alone would increase the extent to which NP tests
were able to capture functional decline due to cognitive loss.
Chapter 4 opens with data collection and participant selection information that
includes a review of the inclusion and exclusion parameters that determined the final
sample size. Descriptive and demographic characteristics of the final sample extracted
from the entire data set provided by NACC. A discussion of the statistical assumptions
necessary for the analyses, and a complete report of the findings organized by the
research questions, including tables that best illustrated the results of the analyses and
effect sizes. The chapter closes with a precise summary of hypotheses testing.
Data Collection
The data set was obtained from the University of Washington’s NACC by
submitting the abstract from the present study and signing a data use agreement. To date,
the NACC coordinated the collection of longitudinal data on 967 different variables for
more than 100,000 participants. This study was limited to only data gathered on the most
recent version of the UDS-3 implemented in March 2015 because it reflected changes in
how dementia syndromes are classified in current clinical practice with an updated
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version of the UDS-3 NAB that allowed researchers to collaborate using freely-available
standardized testing instruments. For a complete discussion on how each ADC enrolls
subjects and gathers data, see chapter 3 “The National Alzheimer’s Coordinating Center
Uniform Data Set 3”. NACC subjects are best described as a referral-based or volunteer
case series and thus are not a statistically representative sample of the population. The
complete UDS-3 NAB data included a robust group of individuals with normal cognition
as well as those with various etiologies of neurodegenerative diseases. The primary goal
of this study was to inform the use of NP tests to differentiate between normal cognitive
aging and dementia in the most commonly encountered situations, so the subjects were
filtered to include only a primary etiologic diagnosis of AD in people 60 years and older
with a CDR-SB score < 9.5. This cutoff excluded individuals with moderate to severe
dementia for reasons fully justified in chapter 3 under “Participant Selection and
Stratification”.
Sample Descriptives
The case processing summary showed no missing data. From the more than
100,000 participants in the full data set, 8724 subjects met all inclusion and exclusion
criteria (n = 8724), 5192 females and 3532 males. They ranged in age from 60 to 101
with an average age of 74. The majority earned a bachelor’s degree with a range of
formal education from 9 years to 21 years. Table 1 contains the descriptive statistics for
all study variables. The frequencies tables were visually inspected for anomalies, these
values all fell within expected ranges.. Table 2 used the outcome measure, to classify the
subjects according to their CDR-SB scores into categories of Normal Cognition, MCI, or
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Demented. The majority of subjects, 6237, fell into the normal cognition range, 1505 had
a diagnosis of MCI, and 982 subjects met the criteria for dementia.

Table 1
Descriptive Statistics for All Variables
Variable

Mean

SD

Min

Max

Range

IQR

Skew

Kurtosis

AGE
74.12 7.87
60
101
41
12
.32
- .46
SEX
.60
.49
0
1
1
1
-.39
-1.85
EDU
16.24 2.51
9
21
12
4
-.32
.20
CDR-SB
.83 1.68
0
9
9
.50
2.53
6.30
MEMO_GEA
-.4595 1.13
-3.83 2.78
6.62 1.47
-.56
-.34
MEMO_GA
-.4635 1.14
-3.69 2.52
6.21 1.48
-.59
-.20
MEMO_GE
-.4592 1.16
-3.56 2.69
6.25 1.51
-.53
-.25
MEMO_G
-.4632 1.17
-3.37 2.43
5.80 1.52
-.52
-.29
EXEC_GEA
-.3411 1.08
-4.59 2.48
7.07 1.12 -1.07
1.36
EXEC_GA
-.3482 1.12
-4.40 2.46
6.86 1.20 -1.07
1.24
EXEC_GE
-.3408 1.11
-4.45 2.59
7.04 1.17 -1.06
1.22
EXEC_G
-.3479 1.15
-4.28 2.56
6.83 1.23 -1.06
1.10
LANG_GEA
-.3459 1.14
-9.09 2.95
12.04 1.24 -1.70
6.16
LANG_GA
-.3528 1.17
-8.91 3.03
11.94 1.29 -1.58
5.36
LANG_GE
-.3457 1.17
-8.88 3.00
11.88 1.27 -1.63
5.66
LANG_G
-.3525 1.20
-8.80 3.01
11.80 1.33 -1.51
4.94
ATTN_GEA
-.1234
.88
-3.32 2.93
6.26 1.18
.27
.05
ATTN_GA
-.1282
.90
-3.39 3.01
6.40 1.20
.28
.05
ATTN_GE
-.1233
.89
-3.41 3.01
6.42 1.20
.28
.04
ATTN_G
-.1280
.91
-3.52 2.83
6.35 1.16
.30
.04
Note. n = 8724. n = 5192 females. n = 3532 males. Memory composite score (MEMO).
Executive function composite score (EXEC). Language composite score (LANG).
Attention composite score (ATTN). Scores corrected for gender, education, and age
(GEA). Scores corrected for gender, and age (GA). Scores corrected for gender, and
education (GE). Scores corrected for gender only, also considered as the “raw” score (G).
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Table 2
Descriptive Statistics Grouped by Dementia Severity Level
Normal
N = 6237

Mean

SD

MCI
N = 1505

Range

Demented
N = 982

Mean

SD

Range

Mean

SD

Range

CDR-SB
.10
.30
2.0
1.23
MEMO_GEA
-.00
.78
5.98
-1.15
MEMO_GA
-.00
.79
5.85
-1.15
MEMO_GE
-.01
.81
5.71
-1.18
MEMO_G
-.02
.82
5.59
-1.19
EXEC_GEA
-.32
.80
6.32
-.71
EXEC_GA
.01
.88
5.89
-.72
EXEC_GE
-.01
.83
6.35
-.74
EXEC_G
-.01
.87
6.71
-.76
LANG_GEA
-.00
.80
7.93
-.84
LANG _GA
.00
.84
8.35
-.85
LANG _GE
.01
.82
8.37
-.87
LANG _G
.02
.86
8.72
-.88
ATTN_GEA
.01
.86
5.64
-.32
ATTN _GA
.01
.88
5.89
-.33
ATTN _GE
.02
.87
5.68
-.34
ATTN _G
.02
.89
5.66
-.35
Note. n = 8724. n = 5192 females. n = 3532 males.

.90
.94
.94
.94
.95
1.06
1.10
1.08
1.15
1.07
1.08
1.09
1.10
.82
.83
.82
.83

5.12
5.12
5.12
5.32
5.00
6.72
6.24
6.44
5.99
10.80
11.01
10.63
10.84
5.83
5.83
5.90
5.89

4.90
-2.31
-2.34
-2.36
-2.39
-1.74
-1.80
-1.80
-1.85
-1.79
-1.84
-1.83
-1.88
-.65
-.69
-.68
-.72

1.70
.81
.81
.80
.80
1.35
1.36
1.36
1.36
1.59
1.58
1.60
1.59
.84
.84
.83
.83

6.50
4.69
4.28
4.23
5.80
5.92
6.40
6.34
6.83
10.56
10.13
10.37
11.80
5.92
6.04
5.97
6.35

Assumption Testing
A preliminary regression analyses was run to look for outliers identified using
standardized and studentized residuals following model fitting. Single data points with
residuals above or below 3.29 were considered for removal as they were unlikely to occur
by chance (Field, 2013). The proportion of cases with standardized residuals greater or
less than 1.96 were also examined because it was desired that 95% of data points fell
within these values for a well-fitting model. Distances were calculated using
Mahalanobis, Cook’s, and Leverage values. Using a Chi-square table P = .001 and 4df,
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the cutoff was 18.47. Cook’s distance values over .00045877 could have been considered
outliers and leverage values over .00114626 could also been considered for removal. No
data violated all three markers and the data set was kept in its entirety without fear that
outliers biased results because of the large size of the data set. Tests to see if the data met
the assumption of collinearity indicated that it was not a concern. VIF and Tolerance
values were examined because VIF > 10 and Tolerance < .02 could be problematic, none
of the values violated those boundaries. The data also met the assumption of independent
errors, Durbin Watson values that were all close to 2 and are included in Table 7.
Histograms and Q – Q plots were visually inspected (see Appendix). The
histograms confirmed normality of the variables. All test score variables were roughly
centered over 0 and the majority of the scores fell between – 2 and 2. Skew and kurtosis
values are included in Table 1, values < 1 are generally considered acceptable but
multiple linear regression does not require normally distributed variables (George &
Mallery, 2016). The slight negative skew for the test variables was expected as
individuals with impaired performance perform below normal. Q – Q plots were
inspected for linearity and observed values adhered well to the line of best fit (expected
values), they were not completely on the line, but close, so there were no obvious
violations of this assumption. The departure from normality appeared more significant as
the values of the CDR-SB increased (a higher dementia severity) which followed logic
that the CDR-SB is more accurate at predicting normal cognition and less accurate at
predicting demented people (see Appendix A). Homogeneity and homoscedasticity were
examined using boxplots. The length of the boxes and their “whiskers” had
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approximately the same spread so there were no obvious violations of this assumption.
The data also met the assumption of non-zero variances as all values were greater than 0.
Pearson correlations also showed no violations of collinearity between the outcome
measure, the CDR-SB, as all values were less than .7. Table 3 contains the correlations
for GEA model; Table 4 shows the GA model correlations; Table 5 shows the
correlations for the GE model, and; Table 6 shows the correlations for the G (raw) model.
The correlations have a negative relationship as expected. The lower the test scores, the
higher the CDR-SB score, in other words people performed worse on the tests as their
dementia severity increased.
Table 3
Pearson Correlations for Gender, Age, and Education Corrected Scores

CDRSUM MEMO_GEA EXEC_GEA ATTN_GEA LANG_GEA
1

-.645**

-.507**

-.240**

-.512**

MEMO_GEA

-.645**

1

.483**

.287**

.559**

EXEC_GEA

-.507**

.483**

1

.463**

.564**

ATTENT_GEA

-.240**

.287**

.463**

1

.305**

LANG_GEA

-.512**

.559**

.564**

.305**

1

CDRSUM

Note. N = 8724. ** p < .001 (2-tailed).

Table 4
Pearson Correlations for Gender and Age Corrected Scores
CDRSUM

MEMO_GA

EXEC_GA

ATTN_GA

LANG_GA

1

-.645**

-.505**

-.248**

-.513**

MEMO_GA

-.646**

1

.501**

.309**

.574**

EXEC_GA

-.505**

.501**

1

.490**

.589**

ATTENT_GA

-.248**

.309**

.490**

1

.335**

LANG_GA

-.513**

.574**

.589**

.335**

1

CDRSUM

Note. N = 8724. ** p < .001 (2-tailed).
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Table 5
Pearson Correlations for Gender and Education Corrected Scores
CDRSUM

MEMO_GE

EXEC_GE

ATTN_GE

LANG_GE

1

-.651**

-.517**

-.255**

-.519**

MEMO_GE

-.651**

1

.511**

.308**

.582**

EXEC_GE

-.517**

.511**

1

.477**

.588**

ATTENT_GE

-.255**

.308**

.477**

1

.325**

LANG_GE

-.519**

.582**

.588**

.325**

1

CDRSUM

Note. N = 8724. ** p < .001 (2-tailed).

Table 6
Pearson Correlations for Raw Scores
CDRSUM

MEMO_G

EXEC_G

ATTN_G

LANG_G

CDRSUM

1

-.651**

-.515**

-.263**

-.520**

MEMO_G

-.651**

1

.528**

.329**

.595**

EXEC_G

-.515**

.528**

1

.503**

.611**

ATTENT_G

-.263**

.329**

.503**

1

.354**

LANG_G

-.520**

.595**

.611**

.354**

1

Note. N = 8724. ** p < .001 (2-tailed).

The bivariate correlations also supported the order of entry into the hierarchical
regression equation for the testing the main hypotheses; memory composite scores
showed the strongest relationship to the CDR-SB (α = -.65, p < .001) so entering memory
scores into the model first was supported; executive function and language composite
scores both demonstrated moderate relationships with the CDR-SB (α = -.51, p < .001) so
they were entered second and third respectively, and; the attention composite scores
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showed a weak yet still statistically significant relationship (α = .25, p < .001) to the CDR
– SB so entering these scores into the regression equation last was also supported.
Regressions to Predict Dementia Severity Rating by Norming Method
Hierarchical multiple regression was conducted to predict CDR-SB, a clinical
measure of functional changes due to cognitive loss, from the memory, executive
function, language, and attention test composite scores that were normed by 4 different
methods. R2 and AIC values were compared to analyze the extent to which the raw scores
and demographically corrected scores influenced the ability of the tests to capture
meaningful variation in the CDR-SB. See Table 7 for an overall summary of the
significance of each of the models by norming method. The individual predictor variable
results for each norming method are reported in Table 8.
The first hierarchical multiple regression was conducted to predict CDR-SB
scores from memory scores, executive function scores, language scores, and attention
scores adjusted for gender, age, and education. Model 1 showed memory test scores
accounted for 41.6% of the CDR-SB variability, R2 = .416, F(1, 8722) = 6213.10, p <
.001. Model 2 showed executive function scores accounted for an additional 5% of the
variability in the CDR-SB, F(1, 8721) = 809.94, p < .001, R2 = .05. Model 3 showed
that language had a smaller yet still significant effect by accounting for 1% of the
variability in the CDR-SB, F(1, 8720) = 169.06, p < .001, R2 = .01. Model 4 showed
that attention scores were again significant even though they only captured .1% of the
variance in the CDR-SB, F(1, 8719) = 19.69, p < .001, R2 = .001. The complete model
captured 47.7% of the variability in the CDR-SB, R2 = .477, p < .001.
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Further analysis demonstrated the significance of each predictor. Memory
accounted for 42% of the CDR-SB score,  = -.65, t(8722) = -78.82, p < .001, pr2 = .42.
In other words, for every one unit decrease in memory scores there was an increase in
dementia severity rating by .65 SD. In the second model executive function accounted for
an additional 9% of the CDR-SB when controlling for memory,  = -.25, t(8721) = 28.46, p < .001, pr2 = .09. In the third model language accounted for another 2% of the
CDR-SB score over and above memory and executive function scores,  = -.13, t(8720) =
-13, p < .001, pr2 = .02. And in the fourth model attention was again a significant
predictor, but only accounted for .22% of the CDR-SB score,  = .04, t(8719) = 4.44, p <
.001, pr2 = .0022.
A second hierarchical multiple regression was conducted to predict CDR-SB
scores from memory test scores, executive function test scores, language test scores, and
attention test scores that were adjusted for gender and age. Memory test scores accounted
for 41.7% of the CDR-SB variability, F(1, 8722) = 6235.38, p < .001, R2 = .417. Model 2
showed executive function scores accounted for an additional 4% of the variability in the
CDR-SB, F(1, 8721) = 809.94, p < .001, R2 = .04. Model 3 showed that language had
a smaller yet still significant effect by accounting for .09% of the variability in the CDRSB, F(1, 8720) = 145.83, p < .001, R2 = .009. Model 4 showed that attention scores
were again significant even though they only captured .2% of the variance in the CDRSB, F(1, 8719) = 27.08, p < .001, R2 = .002. The total model accounted for 47.1% of
the variability in the CDR-SB score, R2 = .471, p < .001.

104
The significance of the predictors for this model showed memory to have the
same value as in the model corrected for gender, education, and age,  = -.65, t(8722) = 78.96, p < .001, pr2 = .42. Executive function accounted for another 8% of the CDR-SB
score when holding memory constant,  = -.24, t(8721) = -26.62, p < .001, pr2 = .08.
Language picked up another 2% of the CDR-SB score when controlling for memory and
executive function scores,  = -.13, t(8720) = -12.08, p < .001, pr2 = .02. Attention,
although statistically significant, only accounted for an additional .31% of the CDR-SB
score over and above the memory, executive function, and language scores,  = .05,
t(8719) = 5.20, p < .001, pr2 = .0031.
The third hierarchical multiple regression was conducted to predict CDR-SB
scores from memory test scores, executive function test scores, language test scores, and
attention test scores that were adjusted for gender and education. Memory test scores
accounted for 42.3% of the CDR-SB variability, F(1, 8722) = 6401.38, p < .001, R2 =
.423. Executive function scores accounted for an additional 4.6% of the variability in the
CDR-SB, F(1, 8721) = 755.64, p < .001, R2 = .046. Language had a smaller yet still
significant effect by accounting for .8% of the variability in the CDR-SB, F(1, 8720) =
139.86, p < .001, R2 = .008. Lastly, attention scores were again significant even though
they only captured .1% of the variance in the CDR-SB, F(1, 8719) = 16.18, p < .001,
R2 = .001. The total model accounted for 47.9% of the variability in the CDR-SB
scores, R2 = .479, p < .001.
The significance for each predictor adjusted for gender and education showed
memory again accounting for 42% of the CDR-SB score,  = -.65, t(8722) = -80.01, p <
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.001, pr2 = .42. Executive function accounted for an additional 8% of the CDR-SB score
over and above memory,  = -.25, t(8721) = -27.49, p < .001, pr2 = .08. Language picked
up an addition 2% of the CDR-SB score,  = -.12, t(8720) = -11.83, p < .001, pr2 =.02.
Attention was again significant while accounting for .18% of the CDR-SB score,  = .04,
t(8719) = 4.02, p < .001, pr2 = .0018.
The fourth hierarchical multiple regression was conducted to predict CDR-SB
scores from raw scores, adjusted for gender only (raw scores). Memory test scores again
accounted for 42% of the CDR-SB variability, F(1, 8722) = 6420.78, p < .001, R2 = .424.
Executive function scores accounted for an additional 4.1% of the variability in the CDRSB scores, F(1, 8721) = 662.44, p < .001, R2 = .041. Language had a smaller yet still
significant effect by accounting for .07% of the variability in the CDR-SB, F(1, 8720) =
120.73, p < .001, R2 = .007. Lastly, model 4 showed that attention scores were again
significant even though they only captured .1% of the variance in the CDR-SB, F(1,
8719) = 22.70, p < .001, R2 = .001. The complete model accounted for 47.3% of the
variability in the CDR-SB scores.R2 = .473, p < .001.
The significance of the predictors for the raw scores showed memory again at
42%,  = -.65, t(8722) = -80.13, p < .001, pr2 = .42. Executive function accounted for an
additional 7% of CDR-SB scores,  = -.24, t(8721) = -25.74, p < .001, pr2 = .07.
Language accounted for 1% of the CDR-SB score,  = -.12, t(8720) = -10.99, p < .001,
pr2 =.01. And attention was again statistically significant while only accounting for .26%
of the CDR-SB scores,  = .04, t(8719) = 4.77, p < .001, pr2 = .0026.
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The gender and education normed model captured the greatest amount of variance
in the CDR-SB with 47.9% . The gender, education, and age normed model accounted for
47.7% of the variance in the CDR-SB. The raw scores accounted for 47.3% of the
variance and the model normed for gender and age captured the least amount of variance
47.1% from the CDR-SB. The differences were small and did not fall into different effect
size categorizations, but an argument can be made that any increase is of significant
clinical value in dementia diagnostic evaluations. Each predictor was significant in every
step of every regression for every norming method. Meaning no matter how the test
scores were normed they all had important relationships with the CDR-SB. As expected,
memory, executive functions, and language test scores significantly predicted the
dementia severity rating in a negative direction, as test scores decreased, the dementia
severity increased. However, an unexpected finding surfaced with the attention scores,
while statistically significant, the contribution to the predicted outcome measure was
much smaller than expected. The best explanation for the small effect size of the attention
domain is that the ability to maintain attention is often well preserved until the later
stages of AD. The majority of the sample group had normal cognition with inclusion
criteria removing participants with a CDR-SB score above 9.5, meaning that individuals
with moderate and severe dementia were excluded from this analysis. This decreased the
lower end scores in the attention composite.
Age-adjusted scores weakened the ability of the model to capture the variance in
the CDR-SB, and the theory that raw scores are superior to other norming methods could
not be supported when using a NP battery approach (Hassenstab et al, 2016; Hessler et
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al., 2014; Holtzer et al.,2008; O’Connell & Tuokko, 2010; Wyman-Chick et al., 2018).
The findings clearly suggested that correction for education is best practice for processing
NP test scores in an older population because the 2 models that included education
correction were superior to the models that did not included education correction. The
model that was only corrected for education, leaving age correction out completely,
captured the most variability in the CDR-SB.

Table 7
Model Summary of Regressions for Prediction of CDR-SB Scores

Model 1

Model 2

Model 3

Model 4

1MEMO_GEA
2 EXEC_GEA
3 LANG_GEA
4 ATTN_GEA

Total
R2
.416
.466
.476
.477

R2
change
.416
.050
.010
.001

1 MEMO_GA
2 EXEC_GA
3 LANG_GA
4 ATTN_GA

.417
.461
.470
.471

1 MEMO_GE
2 EXEC_GE
3 LANG_GE
4 ATTN_GE

.423
.469
.478
.479

1, 8722
1, 8721
1, 8720
1, 8719

F
Change
6213.101
809.944
169.055
19.692

Total
R2
.416
.466
.476
.477

.417
.044
.009
.002

1, 8722
1, 8721
1, 8720
1, 8719

6235.376
708.728
145.833
27.080

.417
.461
.470
.471

1.98

.423
.046
.008
.001

1, 8722
1, 8721
1, 8720
1, 8719

6401.380
755.641
139.859
16.182

.423
.469
.478
.479

1.98

df

Durbin
Watson

1.99

1 MEMO_G
.424
.424
1, 8722
6420.780
.424
2 EXEC_G
.465
.041
1, 8721
662.440
.465
3 LANG_G
.472
.007
1, 8720
120.733
.472
4 ATTN_G
.473
.001
1, 8719
22.703
.473
1.98
Note. n = 8724. All p values were statistically significant p < .001. Memory composite score (MEMO).
Executive function composite score (EXEC). Language composite score (LANG). Attention composite
score (ATTN). Scores corrected for gender, education, and age (GEA). Scores corrected for gender, and
age (GA). Scores corrected for gender, and education (GE). Raw scores (G) corrected for gender only.
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Table 8
Significance of Predictors by Norming Method
Model 1

Predictors

B

SE B

Model 2
β

B

SE B

Model 3
β

B

SE B

Model 4
β

B

MEMO_GEA
-.96
.01
-.65*
-.78
.01
-.52*
-.70
.01
-.47*
-.71
EXEC_GEA
-.40
.01
-.25*
-.32
.02
.20*
-.34
LΑΝG_GEA
-.20
.02
-.13*
-.20
ATTN_GEA
.07
MEMO_GA
-.95
.01
-.65*
-.77
.01
-.52*
-.70
.01
-.48*
-.70
EXEC_GA
-.36
.01
-.24*
-.29
.02
-.19*
-.32
LANG_GA
-.18
.02
-.13*
-.19
ATTN_GA
.09
MEMO_GE
-.94
.01
-.65*
-.76
.01
-.52*
-.69
.01
-.48*
-.70
EXEC_GE
-.38
.01
-.25*
-.30
.02
-.20*
-.33
LANG_GE
-.18
.02
-.12*
-.18
ATTN_GE
.07
MEMO_G
-.93
.01
-.65*
-.75
.01
-.53*
-.69
.01
-.48*
-.69
EXEC_G
-.35
.01
-.24*
-.28
.02
-.19*
-.30
LANG_G
-.17
.02
-.12*
-.17
ATTN_G
.08
Note: n = 8724. *p < .001. Memory composite score (MEMO). Executive function composite score (EXEC). Language composite score (LANG). Attention
composite score (ATTN). Scores corrected for gender, education, and age (GEA). Scores corrected for gender, and age (GA). Scores corrected for gender, and
education (GE). Raw scores (G) corrected for gender only.

SE(B)

β

.01
.02
.02
.02
.01
.02
.02
.02
.01
.02
.02
.02
.01
.02
.02
.02

-.46*
-.22*
-.13*
.04*
-.48*
-.21*
-.13*
.05*
.49*
-.22*
-.13*
.04*
-.48*
-.21*
-.12*
.04*
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Table 9
Comparison of Percentage Accounted for by Each Cognitive Domain (N = 8724)
Model

Memory
Score +
41.6%

Executive
Score +
5.0%

Language
Score +
1%

Attention
Score =
.1%

47.7%

GA

41.7%

4.4%

.9%

.2%

47.1%

GE

42.3%

4.6%

.8%

.1%

47.9%

G

42.4%

4.1%

.7%

.1%

47.3%

GEA

Total

Note: n = 8724. Scores corrected for gender, education, and age (GEA). Scores corrected for
gender, and age (GA). Scores corrected for gender, and education (GE). Raw scores (G)
corrected for gender only.

The models were also compared using AIC values by computing the delta AIC
values as seen in Table 9. The lowest AIC value was the model corrected for gender and
education, which when subtracted from the other AIC values provided the model delta
value. The best model had the lowest AIC value unless another model had a lesser delta
AIC (Burnham & Anderson, 2004). Burnham and Anderson (2004) determined that
models with delta AIC  2 have substantial support and are comparable to the model with
the lowest AIC value. Models with delta AIC  4 to 7 have considerably less support and
those with delta AIC > 10 have essentially no support. This is the same story told by R2
only clearer. Age correction of cognitive tests created an inferior model. The best model
was gender and education corrected model with all the other models having essentially no
support because the other delta AIC values were all > 10.
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Table 10
AIC Values for All Regression Models

GEA
GA
GE
G

AIC Value

Delta AIC Value

3373.47782
3469.066734
3346.239576
3433.620439

24.24
122.83
**
87.38

Note: n = 8724. *p < .001. Scores corrected for gender, education, and age
(GEA). Scores corrected for gender, and age (GA). Scores corrected for
gender, and education (GE). Raw scores (G) corrected for gender only.

Results of Main Hypotheses Testing
The first hypothesis was that age and education correction would increase the
extent to which NP test scores would capture functional decline due to cognitive loss in
dementia. This hypothesis was supported. A comparison of the gender, education, and
age corrected model to the raw score model showed the gender, age, and education model
captured more variance, R2 = .477 than the raw scores, R2 = .473 so the null hypothesis
was rejected.
Subhypothesis 2 was that age correction would decrease the extent to which NP
tests were able to capture functional decline due to cognitive loss in dementia. This
hypothesis was also supported. A comparison of the gender and age corrected model to
the raw score model showed the gender and age corrected scores, R2 = .471 captured less
variance than the raw scores, R2 = .473 so the null hypothesis was rejected.
Subhypothesis 3 was that education correction would increase the extent to which
NP tests was able to capture functional decline due to cognitive loss in dementia. The
comparison between the gender and education scored model, R2 = .479, showed that it
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captured more variance in the CDR-SB than any other model so the null hypothesis was
rejected. In short, the results of this hierarchical multiple regression showed that gender
and education correction of test scores captured 47.9% of variance in CDR-SB, giving it
a slight edge over the gender, education, and age corrected model which captured 47.7%
of the variance in the CDR-SB. This was confirmed by the comparison of the AICs for
the models (See Table 10). The best model was the one with the lowest AIC value, the
model corrected for gender and education, and all the other models had essentially no
support.
Summary
The overarching research question examined the effects of different types of
demographic correction on the relationship between cognitive test scores and functional
deterioration due to cognitive impairment as measured by the CDR-SB, a dementia
severity measure. The first hypothesis, that age and education correction increased the
extent to which NP test scores captured functional decline due to cognitive loss in
dementia was supported. The first subhypotheses that age correction decreased the extent
to which NP tests captured functional decline due to cognitive loss in dementia was also
supported. The second subhypotheses, that education correction increased the extent to
which NP tests captured functional decline due to cognitive loss in dementia was strongly
supported. A comparison of the models showed that the education correction model
captured the most variance, R2 = .479, in the CDR-SB score. The results of this
hierarchical multiple regression showed that education correction of test scores made for
a superior model by accounting for 47.9% of variance in CDR-SB. The comparison of the
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AIC values for each model confirmed these findings. The gender and education corrected
scores provided the best model with the other models having essentially no support. Age
correction alone of NP tests in an older population created an inferior model. The
differences between the models corrected for education alone and the education and age
correction model were small, and an argument can be made that any increase is of
significant clinical value. However, the necessary amount of increase or increment that
would make a significant clinical difference on a population level was beyond the scope
of this research. Chapter 5 addresses further interpretation of these findings, as well as
limitations of the study and recommendations for further research.
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Chapter 5: Discussion, Conclusions, and Recommendations
The purpose of this study was to identify optimal normative methods for detecting
pathologic cognitive changes in elderly individuals when using cognitive testing.
Archival data from the NACC provided a large data set on which to perform a
hierarchical multiple regression analyses to determine the strength of the relationships
between cognitive test scores, normed 4 different ways, and the clinical dementia severity
rating as measured by the CDR-SB. Total R2 values and AIC values were compared to
determine which norming method captured the greatest amount of variance, in other
words which of the models garnered the most support. The results of the analysis
revealed the differences between the models were small and did not fall into different
effect size categories, but a clear hierarchy was established with education-corrected
scores demonstrating superiority over the other demographic correction methods. Age
correction weakened the models’ ability to capture variance in the CDR-SB.
The main hypothesis was that age and education correction would increase the
extent to which NP test scores captured functional decline due to cognitive loss in
dementia. This hypothesis was supported. A comparison of the gender, education, and
age scored model to the model composed of raw scores showed the demographically
corrected model captured more variance, R2 = .477 than the raw scores, R2 = .473. The
first subhypothesis was that age correction would decrease the extent to which NP tests
captured functional decline due to cognitive loss in dementia. This hypothesis was also
supported because the comparison between the gender and age corrected model and the
model composed of raw scores showed gender and age corrected scores, R2 = .471

114
captured less variance than the raw scores, R2 = .473. The second subhypothesis was that
education correction would increase the extent to which NP tests captured functional
decline due to cognitive loss in dementia. Support was provided for this hypothesis as the
gender and age corrected model, R2 = .479, captured the most variance in the CDR-SB
when compared to all other models. Age correction subtracted from the model’s ability to
capture variance. While the differences were small, they suggested the superiority of the
gender and education corrected model over all others. The major limitation to these
results is that further work is necessary to determine the extent of the difference in R2
value that is required to make this clinically significant on a population level as no
universally accepted criteria exists. Had the models fallen into different effect size
categories the interpretation of the results would have been clearer. All the models had
large effect sizes, R2 values >.40 as per the conventions established by Cohen (1988). It
can be argued that any increases in R2 value is desirable because it may lead to greater
diagnostic accuracy when evaluating for dementia. The current study confirmed that agecorrected scores are the least desirable method of norming in an older population. The
findings of the current study also refute the idea that raw scores are superior to
demographically corrected scores in NP testing when used in the service of dementia
diagnostic evaluations that utilize a NP battery approach.
Interpretation of the Findings
The purpose of norming cognitive tests in the elderly is to provide a point of
comparison for detecting deviant performance that would be indicative of a
neurodegenerative disease such as AD. The findings of the current study provided a clear
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hierarchy between the models; the education-corrected scores generated a superior model
that captured 48% of the variance in the CDR-SB while the age-corrected model
produced an inferior model that captured 47% of the variability in the CDR-SB. A
comparison of the AIC values confirmed that gender and education corrected scores
constructed the superior model. The next step would logically be to determine what
useful clinical significance a 1% increase in R2 translates into at a population level, but
that is beyond the scope of the current study.
Sliwinisky et al., (1996) introduced the idea that conventional norms were not
optimal for detecting deviant performance on cognitive tests because the norms contained
individuals who were already in cognitive decline yet still performed within normal limits
on testing. Their seminal work demonstrated that conventional norms; underestimated
normal performance in the elderly; overestimated the variance in test scores; exaggerated
cognitive decline due to normal aging, especially in the very old, and; produced norms
that were less sensitive to detecting dementia making it more challenging to diagnose.
Sliwinski et al. argued that correcting for age and education decreased the discriminative
validity of their single memory test, and that the uncorrected raw scores were superior for
detecting dementia. The present study challenged their findings by using different
methods of norming to analyze the strength of test scores’ relationships with the gold
standard for clinical dementia severity ratings. The results of the current study partially
supported their work, correcting for age and education did produce an inferior model if
looking only at memory scores. Raw memory scores indeed captured more variation in
the CDR-SB. However, when a battery approach was utilized and executive processes,
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language, and attention scores were taken into consideration, the raw scores did not
capture as much variation as models that included correction for education. It was clear
that when using a typical NP battery approach, adding education correction produced a
better model. Because a diagnosis between normal cognitive aging and dementia is never
determined by a single cut off score in clinical practice, correcting for education is an
essential component when processing scores.
In 2010 O’Connell and Tuokko expanded on Sliwinski et al.’s key idea that
demographic corrections of cognitive test scores may not universally improve dementia
classification accuracy. Their study concluded equivalent overall classification accuracy
of demographically corrected scores and uncorrected test scores but the authors realized
that their findings were of more importance when only one test was used, as in a
dementia-screening evaluation, and of less clinical importance with a typical NP battery
approach. O’Connell and Tuokko conceded numerous limitations in their data given its
novel simulation methodology that necessitated replication to be of any clinical value.
Although their conclusion was overall equivalence between demographically corrected
scores and uncorrected test scores, they did mention that gender and education corrected
scores showed slightly higher accuracy. More work needs to be done to determine the
exact extent of the differences required to deem these small differences in findings as
significant or non-significant. The future direction for research of this type should be to
determine if this number translates into clinical significance at a population level.
Previous work by Sliwinski and colleagues (1996; 1997) focused on a single
memory test score, while later work by Hessler et al. (2014) used a heterogeneous
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composite score that represented multiple cognitive domains. The current study deemed it
unlikely that cognitive domains would be affected by demographic variables in a uniform
manner. Thus, theoretical groupings of particular tests were used to represent different
cognitive domains (memory, executive function, language, and attention). This allowed
for a first-of-its-kind examination of how each domain was affected by demographic
corrections. Raw memory composite score captured the most variation in the CDR-SB
when standing alone, but when the other domains were added and the model was
examined as a whole, the raw scores underperformed the models that included correction
for education (See Table 11). The executive and language composite scores appeared to
benefit the most from gender, age, and education correction. While the attention domain
received a slight increase from age correction but captured the same amount of variability
with all other norming methods. The differences did not fall into different effect size
categories leaving some work to be done on how meaningful the findings are on a
practical level.

Table 10
Comparison of Percentage Accounted for by Each Cognitive Domain (N = 8724)
Model

Memory
Score +
41.6%

Executive
Score +
5.0%

Language
Score +
1%

Attention
Score =
.1%

47.7%

GA

41.7%

4.4%

.9%

.2%

47.1%

GE

42.3%

4.6%

.8%

.1%

47.9%

G

42.4%

4.1%

.7%

.1%

47.3%

GEA

Total

Note: n = 8724. Scores corrected for gender, education, and age (GEA). Scores corrected for
gender, and age (GA). Scores corrected for gender, and education (GE). Raw scores (G)
corrected for gender only.
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Hessler et al. (2014) determined that both corrected and uncorrected scores were
highly significant predictors of progression to dementia even when adjusted for age and
education but observed that education-corrected scores had slightly higher predictive
accuracy. Their overall conclusion was that the differences between the models were
small and did not reach a level of clinical significance, but acquiesced further
investigation was necessary because of the limitations of their study. They questioned the
generalizability of their study because their sample size was composed of a small set of
inpatients (n = 537) who were recruited from 3 general hospitals. Once a patient is
hospitalized, there is a greater chance that their performance on cognitive testing is
compromised which may decrease the variability in the sample and mask clear results in
the analysis. The current study improved on this by using a large data set that included
individuals from across the Nation with a robust normal group, individuals classified as
having normal cognition, as well as those with mild to moderate cognitive impairment
and the same patterns were uncovered. The current study supported their conclusions,
education corrected scores enhanced the relationship between the predictors and the
outcome variable and age-corrected scores were the worst predictors of the outcome
measure.
In 2016 Quaranta et al. aimed to replicate the work of Hessler et al. (2014).
Quaranta et al. (2016) failed to attain results that reached statistical significance and
explicitly stated that their results did not clearly support age correction of test scores
compromised their ability to predict progression to dementia, but acquiesced that, at least
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theoretically, applying age norms in the diagnosis of MCI might partly decrease the
prognostic value over the raw memory scores. Limitations cited by these authors included
the recruitment of participants from general hospitals and not memory clinics, and also
that the sample group was not homogeneous in etiology and included AD dementia, MD,
and non-AD dementia. The current study addressed these limitations by using data from
memory clinics and specified a primary diagnosis of AD dementia for inclusion criteria.
A robust normal control group was also part of the current study design. The current
study supported that age-corrected scores were inferior to raw scores and all other
methods of demographic correction for capturing the amount of variability in the clinical
dementia severity rating. A final thought on age correction, when revisiting the
correlations between the cognitive composite test scores and one another, it appeared that
even after scores were corrected for age and education, relationships still existed between
the test scores and sample demographics. The strongest correlation was between the
CDR-SB and age. It is common knowledge that the incidence of dementia increases with
age, yet some may not consider the unintended consequence of age correcting test scores
in an elderly population and removing the effects of a variable that is scientifically known
to be correlated with dementia.
Strengths and Limitations
A strength of the present study is that it had a large amount of data utilizing the
UDS-3NB, a standardized and clinically sound NP test battery endorsed by the National
Alzheimer’s Coordinating Center. The inclusion criteria specified only AD etiology
which addressed one of limitations cited by a previous researcher who recognized that
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having multiple etiologies of dementia was a limitation because different types of
dementia present with different NP profiles. It also screened out participants in advanced
stages of dementia because again, their testing profiles would be highly variable and less
reliable. Yet, this large data set with its robust normal control group may have also
functioned as a limitation because the number of individuals with normal cognition far
outnumbered those who were demented and this may have obscured larger effect size
differences between the models and diluted the final interpretation of these differences.
Another limitation of this study was the lack of universally accepted criteria for
determining the incremental difference required to make a clinically significant
contribution to clinical practice. When analyzing the significance of each individual
predictors’ contribution to the overall models’ ability to capture meaningful variations in
the CDR-SB score, the differences between the models were small and did not fall into
different effect size categories leaving the final interpretation quite ambiguous. In the
context of dementia evaluations, it can always be argued that any increase in R2 value
leads to greater diagnostic accuracy and may be of practical significance at a population
level. The recommendation for further research is determining how these differences
translate at a population level, in other words what incremental increase confirms or
disconfirms these findings as significant for clinical practice.
Implications
Improved diagnostic accuracy during the earliest stages of a neurodegenerative
process is critically needed to move the field forward so disease-modifying interventions
can succeed before too much irreversible damage is done (Ritchie et al., 2015; Sutphen et
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al., 2015; Villemagne et al., 2012). Refinements in the science of cognitive testing that
distinguish individuals who are experiencing the effects of normal aging from those in
the process of developing neurodegenerative diseases gave rise to the question
concerning the utility of raw scores versus demographically-corrected scores in normreferenced cognitive testing of an older population. The current study explored the
strength of the relationship between tests scored different ways and dementia severity
with the ultimate purpose of finding which way of scoring was most diagnostically
accurate. Using a typical NP battery approach with composite test scores representing
major cognitive domains affected by AD, demographic corrections for gender and
education, leaving age correction out completely, constructed the most accurate model
for predicting the dementia severity rating and highlighted that standard normative
corrections may be insufficient for removing the confounding effects of age, gender, and
education.
Our ability to differentiate between normal cognitive aging and a
neurodegenerative process earlier and with more accuracy has many implications for
positive social change. If leaving out age correction increases the ability of testing to
capture functional loss, it may allow for an earlier or more accurate diagnoses of a
neurodegenerative process. This opens the window for the individual to earlier
intervention, more time to provide evidence-based services that improve the individual’s
quality of life. Drug interventions may slow the progression of the disease while
cognitive rehabilitation can maximize reserved cognitive resources by teaching
compensatory strategies. Behavioral interventions such as diet and exercise increase
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quality of life and prolong a person’s independence. The individual also gains the benefit
of participating in their own care and estate planning. Families benefit when they can
develop and plan strategies to avoid disruption in employment, depletion of finances, and
exacerbation of their own health issues from the emotional stress added by being a care
giver. Society benefits because expenditures for an individual with dementia are 3 times
the cost of care for people without dementia for the same age group causing a huge
financial strain on our Medicare system. Delaying the onset of the disease for just one
year saves resources on the costly and long course of this disease (AA, 2018; Dubois et
al., 2016; Zissimopoulos et al., 2014).
Conclusion
Dementia currently affects approximately 50 million people worldwide; a number
that is projected to grow to 82 million by 2030 and 152 million by 2050. It is the second
largest cause of disability for individuals aged 70 years and older, and the seventh leading
cause of death. Dementia imposes an estimated economic cost of approximately US $818
billion per year globally – or 1.1% of global gross domestic product. Left unaddressed,
dementia could represent a significant barrier to social and economic development
(WHO, 2018). Delaying the onset of the disease, even just for one year, has significant
benefits (AA, 2018; Dubois et al., 2016; Hurd et al., 2013; Langa & Levine, 2014;
Rockwood et al., 2014; Smith & Bondi, 2013; Sperling et al., 2011; Ward et al., 2013;
Wei-Hong et al., 2017; Zissmopoulos et al., 2014). Any improvement in standardized
testing is of value, even if it just detects one case of AD that might have gone
undiagnosed. The results of the current study supported that best practice when
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processing NP test scores in the service of a dementia diagnostic evaluation should
include education correction. It can also be concluded that when we correct for age, we
remove the effects of a variable that is systematically related to the outcome we are trying
to predict simply because the incidence of AD increases with age. Clinicians need to
consider this unintended consequence when utilizing test scores in the service of a
dementia evaluation. Research focused on earlier and more accurate diagnoses is part of
the formula leading to improvements in biomedical, psychological, and social
interventions that have the potential to reduce the number of new cases by 10-20% and
ease the physical, psychosocial, and financial hardships for individuals, their families,
and developing nations (AA, 2018; WHO, 2018).
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